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Abstract: Recent advances (during the 2007–2014 period) in the coordination and 
organometallic chemistry of compounds containing natural and artificially prepared 
radionuclides (actinides and technetium), are reviewed. Radioactive isotopes of naturally 
stable elements are not included for discussion in this work. Actinide and technetium 
complexes with O-, N-, N,O, N,S-, P-containing ligands, as well π-organometallics are 
discussed from the view point of their synthesis, properties, and main applications. On the 
basis of their properties, several mono-, bi-, tri-, tetra- or polydentate ligands have been 
designed for specific recognition of some particular radionuclides, and can be used in the 
processes of nuclear waste remediation, i.e., recycling of nuclear fuel and the separation of 
actinides and fission products from waste solutions or for analytical determination of 
actinides in solutions; actinide metal complexes are also usefulas catalysts forcoupling 
gaseous carbon monoxide,as well as antimicrobial and anti-fungi agents due to their 
biological activity. Radioactive labeling based on the short-lived metastable nuclide 
technetium-99m (99mTc) for biomedical use as heart, lung, kidney, bone, brain, liver or 
cancer imaging agents is also discussed. Finally, the promising applications of technetium 
labeling of nanomaterials, with potential applications as drug transport and delivery 
vehicles, radiotherapeutic agents or radiotracers for monitoring metabolic pathways, are 
also described. 
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Introduction 
The actinide elements have unique physical and chemical properties related to their low-lying 7p, 
6d, and 5f orbitals. Their more common oxidation state is +3, with general electronic configurations 7p 
6d 5fn (where n = 0, 1, 2…, 14). According to this definition, actinium, element 89, is the first  
member of the actinide series of elements, although it has no 5f electrons in its metallic, gaseous, or ionic 
forms [1]. Technetium (element 43) possesses two radioactive isotopes with long half-lives: 99Tc  
(2.12 × 105 years, has practical use) and 98Tc (1.5 × 106 years, it is a rhenium analogue). Both, 
actinides and 99Tc, although able to form metal complexes with ligands containing O-, N-, S- or  
P- heterodonor atoms, have different coordination chemistry, which is largely due to the differences in 
size and electronic structure. However, given their radioactive nature and their common uses as 
radiotracers, fuels, catalysts or radiopharmaceuticals, it makes sense to review the recent literature on 
their particular preparation methods and physical and chemical characteristics. 
Actinides and technetium have numerous applications, but their uses strongly depend on the 
individual properties of each element. In particular, 225Ac, which has a 10-day half-life, is a potential 
agent for α-particle therapy, as it decays emitting three such particles [2]. On the contrary, curium is an 
underexplored element for a variety of reasons. 244Cm has a short half-life of 18 years and radiation 
damage in its compounds is very rapid. 242Cm was also available, but is even shorter-lived with a  
half-life of 163 days. Actinide-containing nanocrystals are currently also an object of intensive 
investigations [3–6]. 
Among the natural and artificial radioactive elements (Tc, Pm, Po, Fr, Ra, Ac and actinides), 
coordination and organometallic compounds of only technetium and the actinide series (An) are well 
represented at the present time [7–10]. The interest on their metal complexes has been motivated by 
the extended use of Tc, available in kilogram amounts, for medical and technical purposes.  
Meanwhile, actinides are important on their own for the nuclear industry and extraction and 
analytical applications [11–13]. They are also used for isotope separation, as antibacterial materials, 
drug delivery and anticancer radiopharmaceuticals, for the creation of labeled biomolecules, and  
radiation-induced processes. In the present review, dedicated to the coordination and organometallic 
chemistry of the actinides and Tc, we intended to present the synthetic techniques for these compounds 
according with the ligand nature. 
Part A. Actinides Chemistry 
A.1. General Concepts on Actinide Complexes 
The electronic states of actinide atoms and ions are significantly different from those of lanthanides. 
In both series the successive filling of the f level proceeds up to the f14 configuration, but in the 
actinide series the filling only formally starts with Th, which has no f electrons and is the electronic 
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analog of Hf. In contrast to lanthanides, the actinides display a wide collection of oxidation states. As 
An3+ ions they are analogs of the related Ln3+ ions, but as An4+ they resemble both Hf(IV) and Ce(IV) 
compounds. Actinides form various Anm+ (m = 2–4) and AnO2m+ (m = 1, 2) ions containing only f 
electrons. The shielding by f electrons causes the contraction of the An3+ ions and the magnitude of the 
actinide contraction along the series to be parallel to that of the lanthanide contraction. Differences in 
correlation between the energy of 5f and 6d, as well as the 4f and 5d, levels lead to noticeable 
differences in the magnetic properties and electronic spectra of Lnm+ and Anm+ ions. Technetium 
(4s24p64d55s2 or 4s24p64d65s1) has oxidation states from +1 to +7, however, those from +4 to +7 are 
the most stable.  
Spin-orbit coupling (J) for the An3+ ions is very strong (2,000–4,000 cm−1) and larger that those for 
the Ln3+ ions (ca. 1,000 cm−1). In contrast to lanthanides, J is comparable with the ligand-field splitting 
and is no longer a good quantum number. The proximity of the energy of the 5f and 6d orbitals and the 
population of thermally accessible excited levels lead to the expression for effective magnetic moment 
μe = g[J(J + 1)]1/2 being appropriate for the lanthanides, but not for actinides.  
Actinide organometallic complexes are compounds containing an actinide-carbon π-bond, an  
actinide-carbon σ-bond, or a combination of both. Actinide organometallic complexes are known for all of 
the early actinide elements (An) from thorium through californium. However, the majority of the reported 
data is on Th and U organometallic chemistry due to the extremely long half-lives of commercially 
available 232Th (in the form of ThCl4) and 238U (as UCl4) (1.41 × 1010 and 4.468 × 109 years, respectively). 
Actinides have large metal and ionic radii and, therefore, large coordination numbers (CN) of up to 15. 
The uranium 6d orbitals play the primary role in covalent bonding between the metal and the ligand, 
while the 5f orbitals have a secondary role.  
In contrast to lanthanides, the actinides have a variety of oxidation states in aqueous solution. The 
stable oxidation states go from +3 for Ac to +6 for U and Np and then successively decrease to +3 for 
Am and succeeding elements except No(+2). The maximum and stable oxidation states coincide for 
Ac, Th, Pa, U, Md, and Lr. Stable states are +7 for Np and Pu, +6 for Am, +4 for Cm, Bk, Cf, Es, and 
Fm, and +3 for No. The unstable (except for No and Md) oxidation state +2 is known for nearly all 
actinides in aqueous solution. The An2+, An3+, An4+, AnO2+, and AnO22+ hydrated ions are known, 
which act as Brönsted acids.The An4+ cations are characteristic for actinides from Th through Cf (U4+ 
is readily oxidized) and in the case of Th is the only one existing in solution. Their acidity decreases in 
the order Pa4+ >> U4+ > Pu4+ > Np4+ > Th4+. The monoatomic ions exist only in very dilute solutions 
and tend to form polynuclear species when the concentration is increased. The acidity of the Ann+ ions 
depends on the charge and radius of the central atom, so the An4+ and AnO22+ ions are much stronger 
acids than An3+ and AnO2+, respectively. The redox behavior of the actinides is complicated by their 
high radioactivity, leading, in particular, to formation of H2O2 in aqueous solutions.  
Moessbauer spectroscopy is a very useful tool to deduce the oxidation state and symmetry of the 
ligand environment. The gamma-resonance effect is observed for 232Th, 231Pa, 238U, 240Pu, 243Am, and 
especially for 237Np with a 237U source. The isomer shifts for Np(VII) compounds are the largest (up to 
−70 mm/s) and decrease to +30 mm/s for Np(III).  
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A.2. Actinide Complexes with O-Containing Ligands 
Although actinide metal complexes with the simplest inorganic ligands like water and anions were 
well studied in the previous century, sometimes novel and fresh ideas and calculation results on their 
structures and properties appear in the available literature. Thus, Car-Parrinello molecular dynamics 
simulations were used to examine the hydration structures, coordination energetics, and the first hydrolysis 
constants of Pu3+, Pu4+, PuO2+, and PuO22+ ions were determined in aqueous solution at 300 K. It was 
found that the hexavalent PuO22+ species are coordinated to five aquo ligands while the pentavalent 
PuO2+ complex is coordinated to four aquo ligands. The Pu3+ and Pu4+ ions are both coordinated to 
eight water molecules. The first hydrolysis constants obtained for Pu3+ and PuO22+ are 6.65 and 5.70, 
respectively, all within 0.3 pH unit of the experimental values (6.90 and 5.50, respectively) [14]. 
Among other simple ligands, carbonates and borates have been also studied. Thus, curium(III) is able 
to form a stable complex in a high ionic strength aqueous solution, in the temperature range of 10–70 °C, 
as demonstrated recently by a time-resolved laser-induced fluorescence spectroscopy study [15]. 
Borate complex Cm2[B14O20(OH)7(H2O)2Cl] was synthesized [16] in autoclave using 248CmCl3 (3% 
246Cm) and boric acid as the starting materials. Its crystallographic (Figure 1) and spectroscopic studies 
provided complementary information about this complex CmIII borate. Both confirmed two distinct 
sites that are averaged in the crystal structure. It was hypothized that actinide borate compounds yield 
very distinct chemistry among 5f elements because of the large polarizability of the BO3 units. This 
yields unusual bonding with 5f orbitals that is absent in most other ligand systems.  
Figure 1. Views of two different coordination environments of CmIII sites in 
Cm2[B14O20(OH)7(H2O)2Cl] with resolved disorder. (a) Nine-coordinated Cm(III) 
complex; (b) Ten-coordinated Cm(III) complex. 
 
Organic ligands are obviously represented by a major number of examples. Thus, the structure of 
the dimethyl sulfoxide (DMSO)-solvated thorium(IV) ions was studied in solution by EXAFS) and the 
structure of the solid oxonium bis[nonakis(κO-dimethyl sulfoxide)]thorium(IV) trifluoromethane-sulfonate 
dihydrate, (H3O)[Th((CH3)2SO)9]2(CF3SO3)9·2H2O was determined [17]. It consists of two individual 
nonakis(κ-O-dimethyl sulfoxide)thorium(IV) units, both of which have a tricapped trigonal prismatic 
configuration, as also found earlier in nonakis(dimethyl sulfoxide)thorium(IV) perchlorate. The 
(b) (a) 
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DMSO-solvated thorium(IV) ion is nine-coordinate in both solution and the solid state with  
average Th-O bond lengths of 2.45 Å. On the contrary, the dmso-solvated lanthanoid(III) ions  
are eight-coordinate. 
Actinide carboxylates have been extremely widely studied. Thus, the results on the optical 
absorption and symmetry of the Np(V) complexes with dicarboxylate and diamide ligands (Figure 2) 
are reviewed [18]. It was demonstrated that the optical absorption properties of the Np(V) complexes 
are governed by their symmetry. The presence of carboxylates could lead to changes in the forms of 
actinide ions in solution. For example, hydrated actinide(IV) ions undergo hydrolysis and further 
polymerization and precipitation with increasing pH [19]. The resulting amorphous and partly 
crystalline oxydydroxides AnOn(OH)4 − 2n·xH2O can usually be observed as colloids above the An(IV) 
solubility limit. The aging process of such colloids results in crystalline AnO2. The colloids can be 
avoided in the presence of carboxylates, forming polynuclear complexes in the solution, in a 
competition in between complexation and hydrolysis. Most of these polynuclear complexes poses a 
hexanuclear core with general formula [An6(μ3-O)4(μ3-OH)4]12+ terminated by 12 carboxylate ligands. 
The An(IV) carboxylates show An-An distances which are ~0.03 Å shorter than the An-An distances 
in AnO2 like colloids. In addition, the complexation of Eu(III), Am(III) and Cm(III) with dicarboxylate 
anions with O, N or S donor groups was measured in I = 6.60 mol/kg (NaClO4) at temperatures of  
0–60 °C by potentiometry and solvent extraction [20]. It was shown that, despite their endothermic 
complexation enthalpies, these complexes are stable due to their high complexation entropies.The 
formation of 1:1:1 ternary complexes of M(EDTA)with the dicarboxylate moiety may favors the 
formation of several coordination environments of these ternary complex, behaving as bidentate or 
monodentate coordination modes, depending of the chain length in between both carboxylate 
coordinating groups (1, for malonate to 4 for adipate). 
Figure 2. Oxydiamide and dicarboxylic acid ligands: (a) oxalic acid (ox), (b) oxydiacetic acid 
(ODA), (c) iminodiacetic acid (IDA), (d) dipicolinic acid (DPA), (e) Nmethyliminodiacetic 
acid (MIDA), (f) N,N,N',N'-tetramethyl-3-oxa-glutaramide (TMOGA).  
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Among particulate carboxylates, uranyl complexes (Figure 3) with phenylalanine and the analogous 
ligand phenylpropionate were investigated in aqueous solution by attenuated total reflection (ATR) 
Fourier transform infrared (FT-IR) spectroscopy [21].  
Figure 3. Chemical structures of the ionic forms of L-phenylalanine and of the proposed 
uranyl(VI) complex. 
 
A bidentate binding of the carboxylate group to the actinide ion was observed by the characteristic 
shifts of the carboxylate modes. The carboxylate functional group was found to be predominant for the 
binding of the heavy metal ion.Complexes with other organic acids are also common. Thus, the 
complexation of protactinium(V) by oxalate was studied by a series of methods, indicating the 
formation of a highly charged anionic complex. The formation constants of PaO(C2O4)+, PaO(C2O4)2−, 
and PaO(C2O4)33− were determined from solvent extraction data by using protactinium at tracer scale 
(CPa < 10−10 M). Complexation reactions of Pa(V) with oxalate were found to be exothermic with 
relatively high positive entropic variation [22]. The complexation of americium(III) with salicylic acid 
(Figure 4a) was studied [23] at trace metal concentrations using a 2.0 m long path flow cell for  
UV-Vis spectroscopy.  
Figure 4. (a) Salicylic acid; (b) citrate anion, (c) nitrilotriacetic acid. 
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Americium(III) has a very low threshold detection limit of 5 × 10−9 M in water at pH 3.0. It was 
found that at pH 5.0 in an aqueous 0.1 M NaClO4 solution, two novel Am(III)-salycylate complexes 
were formed, as indicated by a red shift of its characteristic absorption band (λmax) in the UV-Visible 
spectra. We would like to note that americium evolves in nuclear power plants and contributes to the 
activity of radioactive waste, so, it has to be considered in radioactive waste management.  
Figure 5. (a) ORTEP representation of [Co(NH3)6][Am(NTA)2(H2O)]·8H2O. Thermal 
ellipsoids are drawn at the 50% probability level, H atoms omitted for clarity. Dashed lines 
indicate H-bonding interactions; (b) coordination polyhedron of the Am atom showing 
distorted tricapped trignal prism. 
 
Figure 6. (a) ORTEP representation of [Co(NH3)6]2K[Am3(Cit)4(H2O)3]·18H2O. Thermal 
ellipsoids are drawn at the 50% probability level, H atoms and coordination water 
molecules omitted for clarity; (b) coordination polyhedra of Am atoms. Symmetry 
transformations: A – (1 − x, y, 0.5 − z); B – (1 − x, −y, 1 − z); C – (−x, y, 0.5 − z). 
 
Only a few publications concerning the complexation of Am(III) with inorganic and organic ligands 
are available, especially for the complexation with humic substances [1] and chelating agents. The 
binary complexation of Am3+, Cm3+ and Eu3+ with citrate anion was studied at I = 6.60 m (NaClO4) in the 
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temperatures range of 0–60 °C employing a solvent extraction technique with di-(2-ethylhexyl)phosphoric 
acid/heptanes [24]. Two complexes, MCit and MCit2, were formed at all temperatures. Positive 
enthalpy and entropy values for the formation of both complexes were interpreted as due to the 
contributions from the dehydration of the metal ions exceeding the exothermic cation–anion pairing. In 
addition, two types of ligands that have in common three carboxylic groups, namely the citric acid 
(citric anion, see Figure 4b) and nitrilotriacetic acid, Figure 4c), and their americium complexes 
[Co(NH3)6][Am(NTA)2(H2O)]·8H2O (Figure 5) and [Co(NH3)6]2K[Am3(Cit)4(H2O)3]·18H2O (Figure 6) 
were discussed [25]. In all cases the americium complexes were found to be isostructural with their  
Nd equivalents. 
A.3. Actinide Complexes with N, N, O- and N,S-Containing Ligands 
A.3.1. Complexes with N-Containing Ligands 
Actinide complexes with N-containing ligands are represented by a variety of examples. Thus, the 
terminal uranium(V) nitride complex [UN(TrenTIPS)][Na(12-crown-4)2] {in which TrenTIPS = 
[N(CH2CH2NSiPri3)3]3− and Pri = CH(CH3)2} (Scheme 1) was prepared by reaction of the uranium(III) 
complex [U(TrenTIPS)] with sodium azide followed by abstraction and encapsulation of the sodium 
cation by the polydentate crown ether 12-crown-4 [26].  
Scheme 1. Reaction scheme for formation of [UN(TrenTIPS)][Na(12-crown-4)2]. 
 
A uranium-terminal nitride bond length of ∼1.825 Å was revealed. It should be noted that uranium 
nitride [U;N]x compounds may become an interesting alternative nuclear power source, although there 
is not too much information about their potential use and properties. It was shown [27], that a terminal 
uranium nitride complex can be generated by photolysis of an azide precursor (Scheme 2). The 
transient U,N fragment is reactive and undergoes insertion into a ligand C-H bond to generate new  
N-H and N-C bonds. A complex [C(NH2)3]3[NpO2(CrO4)2](H2O) of Np(V) with the chromate ion and 
an organic outer-sphere guanidinium cation (Figure 7) was isolated from an aqueous solution [28]. Its 
structure is based on anionic chains [CpO2(CrO4)2]n3n− (Figure 8) between which exist guanidinium 
cations and crystallization water molecules. Coordination polyhedra of the Np atoms (pentagonal 
bipyramids) in the anionic chains are joined in pairs through common equatorial edges. 
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Scheme 2. Photolysis of azide complex (left) generates a transient terminal uranium  
nitride (right). 
 
Figure 7. Guanidinium cation. 
NH2
H2N NH2  
Figure 8. Anionic chain [CpO2(CrO4)2]n3n− in the structure of 
[C(NH2)3]3[NpO2(CrO4)2](H2O). Thermal vibrational ellipsoids are shown with the  
50% probability. 
 
5- and 6-member heterocycles containing N-atoms are also known as ligands in actinide complexes. 
Thus, the selectivity of N-donor containing ligands such as BTPs (alkylated bis-triazinylpyridines), for 
actinide complexation in the presence of lantanides, was investigated [29]. NMR studies of an Am  
(n-PrBTP)33+ complex (Figure 9) with a 15N labelled ligand showed that it exhibits large differences in 
15N chemical shift for coordinating N-atoms in comparison to both lanthanide(III) complexes and the 
free ligand. The temperature dependence of NMR chemical shifts observed for this complex indicated 
a weak paramagnetism. On the basis of this fact and the observed large chemical shift for bound 
nitrogen atoms, the authors concluded that metal–ligand bonding in the reported Am(III) N-donor 
complex has a larger share of covalence than in lanthanide complexes. Also, the interaction between 
neptunium(IV) and room-temperature ionic liquids {BmimCl (1-butyl-3-methylimidazolium chloride), 
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BmimMsu (1-butyl-3-methylimidazolium methylsulfate) and BmimSCN (1-butyl-3-methyl-
imidazolium thiocyanate)} was studied [30]. They might be useful for the recycling of nuclear fuel and 
the separation of actinides and fission products from waste solutions.  
Figure 9. Structure of Am(n-PrBTP)33+ complex. 
 
Bipyridine adducts are very common [31–36] for actinide complexes, as well as in whole in 
coordination chemistry. As an example, the addition of 2,2'-bipyridine to [U(TpMe2)2I] {TpMe2  
hydro-tris-(3,5-dimethylpyrazolyl)borate ligand} resulted in the displacement of the iodide and the 
formation of the cationic uranium(III) complex [U(TpMe2)2(bipy)]I, isolated as a dark-green solid in good 
yield [37]. These complexes exhibit a slow relaxation of magnetization (energy barrier of 18.2 cm−1), with 
a Tc of 4.5 K with frequency dependent magnetic properties, characteristic of single-molecule-magnet 
behavior (currently only the third example of a uranium compound with such behavior). Also, the 
solid-state structure of the known complex [Et4N][U(NCS)5(bipy)2] (Figure 10) was re-determined and 
a detailed spectroscopic and magnetic study was performed in order to confirm the oxidation states of 
both metal and bipy ligand [38]. On the basis of electronic absorption, infrared spectroscopy data, 
emission spectroscopy and variable temperature magnetic measurements it was suggested that the 
uranium is in its +4 oxidation state. The bipy ligands are neutral, innocent ligands and not, as would be 
inferred from just a solid state structure, radical anions. 
Figure 10. Solid-state structure of [Et4N][U(NCS)5(bipy)2]. Selected average bond lengths 
(Å): U–NNCS = 2.422; U–Nbipy = 2.636; N=C=1.166; C=S=1.618. 
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A few examples of actinide macrocycle complexes on the basis of N-containing heterocycles are 
known. Thus, syntheses of the bimetallic uranium(III) and neptunium(III) complexes [(UI)2(L)], 
[(NpI)2(L)], and [{U(BH4)}2(L)] (Scheme 3) of the Schiff-base pyrrole macrocycles L are described [39].  
Scheme 3. Synthesis of binuclear UIII and NpIII complexes of the Schiff-base pyrrolic 
macrocycles H4L, H4L', and H4L''.  
 
Fitting of the variable-temperature solid-state magnetic data allowed the prediction of polymeric 
structures for these compounds in the solid state. In addition, thorium(IV) and uranium(IV) 
macrocycles of Mes2(p-OMePh)corrole were synthesized [40] via salt metathesis (Scheme 4) with the 
corresponding lithium corrole in remarkably high yields (93% and 83%, respectively). Both complexes 
are dimeric, having two metal centers bridged via bis(μ-chlorido)linkages. In each case, the corrole 
ring showed a large distortion from planarity, with the Th(IV) and U(IV) ions residing unusually far 
(1.403 and 1.330 Å, respectively) from the N4 plane of the ligand.  
Distinct amines also form a series of complexes with actinide ions. Thus, the extraction of Th(IV) 
with N-n-octylaniline and trioctylamine (TOA) in xylene, from an acid aqueous sulphuric acid was 
reported [41]. The effects of varying the concentration of sulphuric acid, N-n-octylaniline and 
trioctylamine on the distribution ratio of thorium were studied. Based on the obtained results, the 
possible extraction mechanism is shown in reactions (1–2). The method can be extended to the 
analysis of thorium in monazite sand and the gas mantle: 
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Th4+ + 3SO42− ↔ [Th(SO4)3]2−  (1)
mRR′-NH + nR''3N + [Th(SO4)3]2− ↔ mRR′ NH+2.Th(SO4)32−.n R''3NH+ (2)
where R = C6H5 and R' = R'' = C8H17. 
Scheme 4. Synthesis of thorium(IV) corrole and uranium(IV) corrole. 
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The electronic structures of two uranium compounds supported by redox-active α-diimine  
ligands, (MesDABMe)2U(THF) (Figure 11a) and Cp2U(MesDABMe) (Figure 11b) (MesDABMe = 
[ArN=C(Me)C(Me)=NAr]; Ar = 2,4,6-trimethylphenyl (Mes)), were investigated [42] using both 
density functional theory and multiconfigurational selfconsistent field methods. It was established that 
both uranium centers are tetravalent, that the ligands are reduced by two electrons, and that the ground 
states of these molecules are triplets. Energetically low-lying singlet states are accessible, and some 
transitions to these states are visible in the electronic absorption spectrum. The computational analysis 
presented supports the reduction of all α-diimine ligands in these compounds by two electrons, which 
was demonstrated experimentally.  
Figure 11. Molecules used for computational study. Aryl groups have been omitted for clarity. 
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Finally, the fluorinated diarylamines HNPhPhF, HNPhF2, HNPhArF, PhF = 2,3,4,5,6-pentafluoro-phenyl, 
ArF = 3,5-bis(trifluoromethyl)phenyl, were used to prepare homoleptic complexes of uranium(III, IV) ions 
from UI4(Et2O)2 (Scheme 5) [43]. Despite being electronpoor amines with little steric bulk, their 
coordinated amide ligands exhibited direct control over the coordination environment through a subtle, 
cooperative interplay of multiple labile F/U dative interactions and favorable arene–arene interactions. 
Scheme 5. Synthesis of uranium(IV) diarylamide complexes from UI4(Et2O)2. 
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Containing extremely large metal atoms, actinide complexes could have unusual structural 
characteristics. Thus, the synthesis and studies of the first 15-coordinate complex (Figure 12) was 
reported [44].  
Figure 12. Molecular structure of [Th(H3BNMe2BH3)4] from neutron diffraction data. 
Ellipsoids are drawn at the 20% probability level. Th orange, B tan, N purple, C black, H blue. 
 
Reaction of ThCl4 with four equivalents of sodium N,N-dimethylaminodiboranate, 
Na(H3BNMe2BH3), in THF produced [Th(H3BNMe2BH3)4], which could be isolated as colorless 
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prisms by crystallization from diethyl ether. DFT calculations suggested that this complex may adopt a 
16-coordinate structure in the gas phase. The isolated molecule has full D2d symmetry with a 
coordination number of 16, but that the crowded nature of the inner coordination sphere is sufficiently 
destabilizing that molecule distorts and becomes 15-coordinate in the solid state. This is the hightest 
Werner coordination number for a metal complex reported to the date, and was made possible by 
combining a very large metal atom with very small ligands. 
A.3.2. Actinide Complexes with N,O- and N,S-Containing Ligands 
A series of N,O- and some N,S-containing ligands are represented by a series of Schiff bases, 
iminoacetates and other amino/amido/imino derivatives, among others. Thus, the stability and the 
associated thermodynamic parameters of the binary and the ternary complexes of trivalent Am and Cm 
with iminodiacetate (IDA, Figure 13) and with EDTA+IDA, were determined by using a solvent 
extraction technique for aqueous solutions of I = 6.60 m (NaClO4) at temperatures of 0–60 °C [45]. 
The endothermic enthalpy and the positive entropy reflected the significant effect of dehydration in the 
formation of these complexes at high ionic strength.  
Figure 13. IDA (iminodiacetate). 
 
Functionalized bitopic terpyridine(tpy)-diamide N,O-ligands (Figure 14) were recently developed for 
the group actinide separation by solvent extraction. In order to acquire a better understanding of their 
coordination mode in solution, the protonation and the formation of Am(III) and U(VI) complexes 
with bitopic N,O- containing ligands in methanol/water homogeneous mixtures was studied [46]. 
When the terpyridine moiety contained amide functional groups, the extracting properties of these 
ligands was improved, due tochanges in their basicity. Two predominant inner-sphere coordination 
modes were found from the DFT calculations: one mode where the cation is coordinated by the 
nitrogen atoms of the cavity and by the amide oxygen atoms and the other mode where the cation is 
only coordinated by the two amide oxygen atoms and by solvent molecules.  
Figure 14. Structure of tpy ligands. 
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Also, it was demonstrated that an uranium(III) tris(amide) complex was capable to selectively 
couple CO into a linear ynediolate [OCCO]2− dianion, at ambient conditions (room temperature and 
atmospheric pressure), in catalytic concentrations (Scheme 6) [47].  
Scheme 6. Coupling and functionalization of carbon monoxide by the trivalenturanium 
amide to form a uranium-coordinated ynediolate 1, and then an ene-diolate 2.  
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This compound was able, warming the mixture, to activate a C-H bond of a methyl group across the 
CC triple bond, forming a new CC bond and generating a functionalized enediolate dianion. As a great 
contribution of this research for the area of reductive activation reactions of small, traditionally inert 
molecules such as dinitrogen and carbon dioxide, demonstrated for trivalent uranium complexes, the 
observed ready interconversion between the UIII and UIV oxidation states suggested that catalytic 
systems based on this coupling and functionaliation are viable. It is notable that the reaction occurs 
with such a simple coordination compound—an amide that is made from simple commercially 
available ligands (the precursor amide salt currently costs under €100 per mol). In addition, under mild 
conditions a simple triamidoamine uranium(III) complex (Scheme 7) can reductively homologate CO 
and be recycled for reuse [48]. 
Scheme 7. Reaction of CO with uranium complex (R = SiMe2But). 
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Structural analyses of uranyl complexes with isomers of N,N'-diethyl-N,N'-ditolyldipicolinamide 
(EtTDPA, Figure 15) were carried out using IR spectroscopy and single crystal X-ray diffraction [49]. 
From these analyses, it was determined that complexation takes place through coordination with the 
carbonyl and pyridine nitrogen moieties.  
Figure 15. Structures of (a) Et(o)TDPA, (b) Et(m)TDPA, (c) Et(p)TDPA. 
 
The uranyl complexes showed space groups of Pbca for Et(p)TDPA and P21/n for Et(o)TDPA. 
Also, the magnetic properties of the triangular molecular nanomagnet [UO2L]3 {L = 2-(4-tolyl)-1,3-
bis(quinolyl)malondiiminate} were investigated through electron paramagnetic resonance spectroscopy, 
high-field magnetization and susceptibility measurements [50]. The results showed that [UO2L]3 has a  
non-magnetic groud state (doublet) due to the chiral arrangement of the uranium magnetic moments to 
two opposite positions. Quantum tunneling of the non-collinear magnetization, in the presence of a 
perpendicular external magnetic field results explains its non-axial character of the single-ion crystal field. 
Figure 16. Structure of the suggested metal complex. 
 
Metal complex (Figure 16) of Th(IV), with the amino Schiff base ligand, [N-(2-hydroxybenzyl)-L-
methionine acid] (H3L, Figure 17), was prepared in the presence of triethylamine as a deprotonating 
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agent [51]. The data from thermogravimetricanalysis clearly indicated that its decompositionproceeds 
in four or five steps and theorganic part decomposed in one or twointermediates. The decomposition of 
the complex ended with metal oxide and carbon residue.  
Figure 17. 2-(2-Hydroxybenzylamino)-4-(methylthio)butanoic acid. 
 
The Schiff bases and their complexes were screened for their antibacterial (E. coli, Staphylococcus 
aureus) and antifungal (Aspergillus flavus and Candida albicans) activities. Several Th(IV) and [UO2]+2 
complexes with Schiff base ligands prepared from p-trimethoxybenzaldehyde, p-hydroxy-benzaldehyde 
and 2-aminopyridine (Figure 18) were prepared and their structures and physical and chemical properties 
reported (Figure 19) [52].  
Figure 18. (a) 2N-[3,4,5-trimethoxybenzylidene]aminopyridine and (b) 2N-[4-
hydroxybenzylidene]aminopyridine.  
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Figure 19. The proposed coordination numbers and structures for selected thorium 
complexes of 2-TBAPy and 2-HBAPy. 
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Figure 19. Cont. 
 
These complexes present a wide range of coordination numbers (from 6 to 10), and some of them 
have antibacterial and antifungal action. In addition, light yellow thorium(IV) six-coordinate 
complexes were synthesized by reacting Th(IV) nitrate with Schiff bases (Figure 20) derived from  
3-substituted-4-amino-5-mercapto-1,2,4-triazole and glyoxal/biacetyl/ benzyl in ethanol [53]. All these 
complexes are insoluble in DMF and DMSO. The involvement of both C=N groups in the complex 
formation was suggested, keeping SH groups away from the coordination (Figure 21). 
Figure 20. Schiff bases derived from 3-substituted-4-amino-5-mercapto-1,2,4-triazole. 
 
Figure 21. Proposed structure of thorium Schiff-base complexes. 
 
Dioxouranium(VI) and thorium(IV) complexes of ONO-hydrazone ligand derived from 2-hydroxy-5-
methylacetophenone and 2-furoic acid hydrazide (Figure 22) were synthesized and characterized [54].  
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Figure 22. Hydrazone ligand derived from 2-hydroxy-5-methylacetophenone and 2-furoic 
acid hydrazide. 
 
The compounds show semiconductingbehavior as their conductivity increases with increasing 
temperature. The ligand and its complexes have also been screened for their antibacterial and 
antifungal activities. The isolated complexes are bright in color, quite air stable, can be stored for long 
periods, insoluble in water, soluble to very limited extent in common organic solvents but to a 
considerable extent in DMF and DMSO. Other hydrazone complexes also possess useful applications. 
For instance, thorium(IV) forms a yellow colored water soluble complex with diacetyl monoxime 
isonicotinoyl hydrazone reagent DMIH (Figure 23) in acidic buffer of pH 5.0 with λmax at 352 nm [55]. 
This simple method using DMIH as a spectrophotometric reagent can be applied for the determination 
of thorium(IV) in aqueous medium. 
Figure 23. Structure of diacetyl monoxime isonicotinoyl hydrazone (DMIH). 
 
Mixed-ligand diamagnetic Th(IV) complexes (Figure 24) of the type [M(Q)(L)(NO3)2].2H2O were 
synthesized [56] using 8-hydroxyquinoline as a primary ligand and N- and/or O-donor amino acids 
such as L-threonine, L-tryptophan and L-isoleucine as secondary ligands.  
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Figure 24. Proposed structures and bonding for the 8-hydroxyquinoline complexes. 
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Figure 25. Diazepam [7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepine-2-one]. 
 
The electrical conductance studies of the complexes in DMF in 10−3 M concentration indicate their 
non-electrolytic nature. Bonding of the metal ion takes place through N- and O-donor atoms of the 
ligands. In addition, complexes of diazepam (DZM, Figure 25) with the metal nitrates of thorium and 
uranium were synthesized [57]. The complexes were found to have the general composition 
[L(M1)(NO3)4] and [L(M2)(NO3)2], where L= ligand (DZM), M1 = Th(IV) and M2 = UO2(II). The 
complexes were proposed to be octahedral in geometry. The ligand and its metal complexes were 
screened for their antimicrobial activities on bacteria (E. coli, S. typhi, B. subtilis and S. aureus) and 
fungi (A. niger, A. flavous, P. triticena and F. species). Among other recently reported actinide 
complexes, we note those with amido/amino phenol ligands [58,59] and containing both sulfonate and 
carboxylate groups [60] . 
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A.4. Actinide Complexes with Calixarenes 
Calixarenes (in particular phosphinoylated calixarenes as p-tert-butylcalix[4]arene, forming stable 
thorium complexes with 1:1 and 1:2 stoichiometries in organic media [61], or calixarene-based 
picolinamides and malonamides [62]) feature high coordination ability toward f elements and a great 
potential for actinide/rare earth separation. In particular, they are applied as as macrocyclic ligands for 
uranium(VI) [63], showing endo- and exocavity binding in uranyl-calix[6]arene complexes  
(Figure 26). Calixarene complexes are mainly used for analytical or extraction/separation purposes. 
Thus, a new class of calixarene analogues, pillar[5]arenes, having ten diglycolamide (DGA) pendant 
groups as arms on both rims of the pillar structure, were prepared and their affinity toward Am(III) and 
Eu(III) evaluated, as potential novel chelating agents for rare-earth and actinide extraction (Scheme 8) [64].  
Figure 26. Endo- and exocavity binding in uranyl-calix[6]arene complexes. 
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Scheme 8. The extraction of trivalent Am(III) and Eu(III) cations with three novel 
pillar[5]arenes substituted by ten diglycolamide groups (P5DGAs). 
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These extractants exhibited excellent separation and extraction efficiency, suggesting its significant 
potential for nuclear waste remediation. Laser induced fluorescence experiments disclosed strong 
complexation of the trivalent metal ions with the pillararene-DGA ligands. As a new class of 
extractants with a framework of pillar conformation that is quite different from the calixarene 
extractants, pillararene-based diglycolamides may hold potential for the efficient separation of Eu(III) 
and Am(III) from radioactive liquid nuclear waste. In addition, application of azocalixarene for 
evaluation of thorium content based on the complex of o-ester tetraazophenylcalix[4]arene (TEAC,  
Figure 27) with thorium(IV) in acetate buffer solution was offered [65]. This recommended method could 
be applied for determination of thorium concentration in some monazite ore with high confident results. 
Figure 27. Structure of TEAC. 
 
A.5. Actinide Complexes with P-Containing Ligands 
A few P-containing actinide complexes have been recently reported with classic P-ligands. Thus, 
(Ph4P)2UO2I4.2NCCH3 was prepared [66] according to the reaction (3). The redcrystals were soluble in 
MeCN, but decomposed quickly insolvents such as methanol or THF. It was noted that, whereas 
UO2I2.xH2O is thermally unstable in the solid state at room temperature, the neutral 
UO2I2{OP(NMe2)3}2, UO2I2(OPPh3)2, and UO2I2(py)3, as well as (Ph4P)2UO2I4.2NCCH3, are all stable 
in the solid state at r.t. Extraction of Am(III) and Cm(III) [67], as well as Np(VI) [68], between  
tri-n-butyl phosphate solution and molten calcium nitrate hydrate Ca(NO3)2.RH2O was investigated 
radiochemically. The extraction reaction of Am and Cm in the Ca(NO3)2·RH2O-TBP system is 
considered to be the same as the reaction in the HNO3-TBP system (4). The distribution ratio was 
found to be inversely related to the water activity (in the range of water content R = 3.5–8.0). This 
dependence in the hydrate melt changes according to logaH2O = −0.4, which corresponds to R = 5.0. 
The distribution of Np(IV) between 0.08–4.5 M HNO3(aq,eqm) and 30% tri-n-butyl phosphate was 
modelled, accounting for the formation of 1:1 and 1:2 nitrate complexes and Np(IV) hydrolysis in the 
aqueous phase and the extraction of Np(NO3)4(TBP)2 into TBP [69]. In addition, the role of  
water in the formation of associates from nanosized complexes of uranium in a supercritical carbon 
dioxide (SC CO2) medium was studied [70]. It was found experimentally that water in the SC CO2 
exists in the form of microdrops and at a pressure of 10 MPa and a temperature of 40 °C the 
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UO2(NO3)2·2(C4H9O)3PO (TEP) complex (Figure 28) may take on hydrophilic properties. The 
complex above would concentrate in water microdrops, and its concentration in water microdrops 
gives rise to the formation of associates, the size of which was determined by microdrop dimensions. 
UO2I2.xH2O + 2Ph4PI →(Ph4P)2UO2I4 + xH2O  (3)
M(H2O)n3+ + 3NO3−+ 3TBP → M(NO3)3 3TBP + nH2O  (4)
where M indicates Am or Cm and n indicates the hydration number. 
Figure 28. Schematic diagram of complex structure UO2(NO3)2·2TEP. 
 
A.6. Actinide Organometallic Complexes 
A series of actinide organometallics is known, mainly metallocene-like complexes of uranium and 
thorium {although the arene-bridged complex (μ-toluene)U2(N[tBu]Ar)4 (Ar = 3,5-C6H3Me2) is also 
known [71] }. Thus, gas/solid reactions involving H2 and CO2 with the metallocenes (C5Me5)2UMe2 
and (C5Me5)2U(allyl)2 as solids in the absence of solvent provided an improved method to make 
organouranium hydride and carboxylate products (Schemes 9–11) [72].  
Scheme 9. Reaction of solid (C5Me5)2UMe2 with H2 gas. 
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Scheme 10. Reaction of solid (C5Me5)2U(C3H5)2 with H2 gas. 
 
Scheme 11. Reaction of solid (C5Me5)2U(C3H5) with H2 gas. 
 
The reaction of CO2 (80 psi) with solid (C5Me5)2UMe2 forms the monocarboxylate 
(C5Me5)2U(O2CCH3-κ2O,O')Me, in contrast to the solution reaction that forms the diacetate 
(C5Me5)2U(O2CCH3-κ2O,O')2 in minutes.  
The bipyridyl thorium metallocenes [η5-1,2,4-(Me3C)3C5H2]2Th(bipy) and [η5-1,3-
(Me3C)2C5H3]2Th(bipy) (see also bipy complexes above) were investigated by magnetic susceptibility 
and computational studies [73]. It was revealed that these complexes are not diamagnetic, but they 
behave as temperature independent paramagnets. In addition, they react with Ph2CS to give [η5-1,2,4-
(Me3C)3C5H2]2Th[(bipy)(SCPh2)] and [η5-1,3-(Me3C)2C5H3]2Th[(bipy)(SCPh2)], respectively, in 
quantitative conversions. Also, conformationally restricted ThIV and UIV complexes, [ThCl2(L)]  
and [UI2(L)] (Scheme 12), of the small-cavity, dipyrrolide, dianionic macrocycle trans-
calix[2]benzene[2]pyrrolide (L) (see also calixarene complexes above) were reported and were shown 
to have unusual k5:k5 binding in a bent metallocene-type structure [74]. 
Reaction of the uranium alkyl complex (C5Me5)2UMe2 (Scheme 13) with Et3N·3HF in toluene in 
the presence of a donor ligand (pyridine or trimethylphosphine oxide) resulted in gas evolution and the 
formation of the uranium(IV) difluoride complexes (C5Me5)2UF2(L) (L = NC5H5, Me3P=O) [75]. The 
fluoride complex (C5Me5)2UF2(NC5H5) was reactive against several trimethylsilyl compounds, 
showing that the U-F bond may provide of a new synthetic tool for the preparation of new functional 
groups, presently not available from alkoxide and chloride complexes. 
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Scheme 12. Synthesis of [ThCl2(L)] and [UI2(L)]. 
 
Scheme 13. Formation of uranium(IV) difluoride complexes (C5Me5)2UF2(L). 
 
Recently, a new class of bitopic ligands containing phenantroline and 1,3,5-triazine cores and 
functionalized with picolinamide groups were prepared. The ligands were able to extract and separate 
actinides selectively at different oxidation states [76]. 
Part B. Technetium-99m Chemistry 
B.1. General Concepts on Technetium Complexes 
Technetium (Tc) has no stable isotopes; every form of Tc is radioactive. Due to that, there is not 
almost any natural Tc present on Earth (with the exception of that produced from the spontaneous 
fission product in uranium ores) and most of it has to be produced synthetically. It was first discovered 
in 1937 by Carlo Perrier and Emilio Segrè at the University of Palermo by proving that the 
radioactivity in a molybdenum foil discarded from a cyclotron at Lawrence Berkeley National 
Laboratory was produced by an element with Z = 43. Technetium short-lived metastable nuclide 99mTc 
(T1/2 6.015 h, γ-irradiator) was later isolated by Segrè and Glean T. Seaborg at Berkeley and it has 
been widely used until today as a radiotracer in Nuclear Medicine.  
In the last 10 years, around 1,000 papers have been published, reporting the preparation and 
structural characterization of Tc complexes with a wide variety of ligands, or the use of 99mTc as a 
radiotracer or radio-emitter in nuclear medicine. Specific applications have been reported in bone 
scanning, selective imaging of heart, brain, kidney, liver, lungs and other organs, as well as a 
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radiolabeling agent for tumor tissues. Due to its low γ radiation energy (140 keV), short half-life and 
accessibility, 99mTc has been the most obvious choice in diagnostic nuclear medicine. Some relatively 
recent reviews on the state-of-the-art of Tc based diagnostic imaging agents, radiotracers and 
radiopharmaceuticals [77–83]. The [Tc(CO)3]+ moiety has been widely exploited for the preparation of 
bioorganometallic compounds for radiopharmacy and the development of  in vivo imaging agents [84]. 
Macrocyclic chelating ligands, such as crown ethers have been also reviewed as they may become 
useful as radiopharmaceuticals for heart imaging [85]. 
Radiopharmaceuticals have evolved from simple metal complexes (first generation) with simple 
ligands, to higher complexity ligands or even ligands derived from biomolecules, mimicking lipophilic 
and structural properties to increase biocompatibility, biodistribution and tissue recognition specificity. 
The last two generations have reached clinical application, although chemically are harder targets to 
achieve (Figure 29) [80]. 
Figure 29. Evolution of technetium based radiopharmaceuticals. 
 
B.2. Technetium Complexes with O-Containing Ligands 
The chemistry of Tc octahedral oxo complexes has been recently reviewed [86]. The synthesis and 
characterization of neutral complexes fac-[Tc(CO)3(PR3)((L)] and cis-[Tc(CO)3(PR3)(L)], with  
PR3 = triphenylphosphine or methyldiphenylphosphine and L = acetylacetone or curcumin as the OO 
donor ligand, has been reported [87]. Preparation was achieved from the corresponding intermediate 
aqua complexes [Tc(CO)3(H2O)(L)] in the presence of the appropriate tertiary phosphine, which 
replaced the labile water molecule at room temperature. Under reflux conditions, a second phosphine 
ligand displace a carbonyl, generating the bisphosphine complex cis-trans-[Tc(CO)2(PR3)2(L)] in 
almost quantitative yield. Selective binding to beta-amyloid plaques for both the monophosphine and 
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the bisphosphine complexes of curcumin was reported, making these compounds potentially useful for 
pharmacological uses. 
Antibiotics such as ofloxacin, sitafloxacin, sparafloxacin, norfloxacin, garenoxacin, trovafloxacin, 
ciprofloxacin and norfloxacin, have been explored as ligands to prepare technetium-99m tricarbonyl 
complexes (Figure 30). These complexes have been tested against S. aureus as a bacterial infection 
model both in vitro (bacterial cultures) and in vivo (infected rats). All these molecules share a common 
fluoroquinolone skeleton. Fluoroquinolones are broad-spectrum antibiotics with good oral absorption 
and excellent bioavailability. They possess a carboxylic acid function at the 3-position and a carbonyl 
oxygen atom at the 4-position, becoming potentially good bidentate chelating ligands toward metal 
ions. Preparation of the dithiocarbamate derivative in some cases was explored, in order to use the-CS2 
fragment as a coordinating moiety toward the 99mTc ion. Good biodistribution and high accumulation 
in the infected region make these complexes suitable for applications as radiotracer for infection 
imaging [88–96]. Doxycycline, another antibiotic used for the treatment of several infections and part 
of the tetracycline class, has been also labeled with 99mTc to explore its use as a radiotracer for 
infection imaging [97]. It also has several chelating moieties, which makes it a versatile ligand for 
coordination to metal ions (Figure 31). Stability, sterility and in vivo distribution in an animal model 
(rats) were performed, finding high uptake in bacterial infection site, yielding promising results. 
Figure 30. Antibiotics containing the fluoroquinolone skeleton used to prepare potential 
infection radiotracer imaging agents: (i) Oxoflacin; (ii) Sitafloxacin; (iii) Sparafloxacin; 
(iv) Norfloxacin; (v) Garenoxacin; (vi) Trovafloxacin; (vii) Ciprofloxacin. In the box, chelating 
modes of fluoroquinolones and its dicarbamathe derivatives are shown for sitafloxacin. 
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Figure 31. Molecular structure of doxycycline. 
 
B.3. Technetium Complexes with N-, O-, P- or S-Containing Ligands 
Several technetium coordination complexes with chelating ligands (bi-, tri- and tetradentate) 
containing at least a nitrogen atom have been reported in the past decade. These ligands seek to 
overcome problems related to the use of the Tc(I) core as a radiotracer in a metal complex, as they 
need to be hydrophilic. However, most of the chelating agents are lipophilic, contributing to a poor 
pharmacokinetic performance. Several of those chelating ligands, coordinate to different 99mTc targets, 
such as [Tc(CO)3]− or [TcO3]+. For example, the reaction between [TcO4]− and the strong Lewis acids 
benzoyl chloride and BF3.OEt2, was explored for the synthesis of complexes containing the 
[TcO3]−core with ligands such as 2,2'-bipyridine, 1,10-phenantroline, di-1H-pyrazol-1-yl acetate, 
bis(3,5-dimethyl-1H-pyrazol-1-yl)acetate, 1,1,1-methanetriyltris(3,5-dimethyl-1H-pyrazole), and their 
99Tc NMR spectra recorded; their rhenium analogues were also structurally characterized [98] . Water 
soluble 99mTc complexes with sugar-substituted bipyridine complexes obtained from the reaction of 
4,4'-dibromomethyl-2,2'-bipyridine with 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosylthiol, 2,3,4,6-tetra-
O-acetyl-β-D-galactopyranosylthiol or 2,3,4,6-tetra-O-acetyl-α-D-thioacetylmannopyranoside were 
obtained and fully characterized (Figure 32).  
Figure 32. Example of bidentate 99mTc complex: a sugar substituted bipyridine Tc-complex. 
 
The complexes are stable for several hours in the presence of coordinating ligands (histidine), 
showing partial ligand-exchange after 24 h [99]. In other work, the preparation of 99mTc complex with 
a bidentate 6-(pyridine-2-methylimine)-4-[3-bromophenyl)amino]-quinazoline ligands was reported 
recently [100]. This metal complex was explored for use as a biomarker for EGFR positive tumors, 
observing inhibition of the EGFR autophosphorylation. Finally, a series of myocardial perfusion 
imaging agents was prepared using different mono- and bidentate ligands (imidazole, 1,10-phenanthroline, 
2,2-bipyridine) labeled with tricarbonyl-99mTc were reported and fully characterized [101].  
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Dihydropyrimidinone [102] and bemzamidoxime [103] derivatives were synthesized and their 99mTc 
complexes prepared using stannous chloride as reducing agent. Their potential uses are as  
radiotracers for infections (E. coli) or lung radioimaging, showing good biodistribution and stability. 
The complexes were prepared from sodium pertechnate or 99mTc-glucoheptonate, with high 
radiochemical yields. 
Other 99mTc complexes with tridentate and tetradentate ligands containing at least a nitrogen donor 
atom, were prepared, characterized and their use as biomedical radiotracer agents explored. Figures 33 
and 34 show the common chelating groups used to tri-coordinate and tetra-coordinate technetium into 
a complex, respectively. Tables 1 and 2 summarize some selected examples of this type of 99mTc 
chelating ligands reported in the lapse time of this review. 
Figure 33. Type of chelating group present at the 99mTc complexes shown in Table 1. 
 
Figure 34. Type of chelating group present at the 99mTc complexes shown in Table 2. 
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Table 1. Synthesis of 99mTc complexes with chelating tridentate N containing ligands. 
Denticity 
and Donor 
Atoms 
Conjugated Ligand  
Chelating 
Group 
Potential Medical Use Ref. 
N,N,N Benzothiazole and stilbene  II Brain imaging [104] 
 Lys-NHCONH-Glu inhibitor  II 
Imaging of prostate specific 
membrane antigen (PSMA) 
[105] 
 Cyclo-[Arg-Gly-Asp-D-Tyr-Lys(PZ)] I 
Integrin receptors in tumor 
cells and neovasculature 
[106] 
 
Ala-NLe-cyclo[Asp-His-DPhe-Arg-
Trp-Lys]-NH2 
I 
Imaging of melanocortin type 
1 receptor (MC1R) in 
melanoma tumors 
[107] 
 
Lysine aminoacid derivatives 
conjugated to octreotide 
III Tumor imaging [108] 
 
16-mer peptide nucleic acid sequence 
H-A GAT CAT GCC CGG CAT-
Lys-NH2 
I 
Radioimaging human 
neuroblastoma cells 
[109] 
 
Diethyl phosphonate, phosphoric acid 
and bisphosphonic acid derivatives  
I Bone imaging [110] 
 L-Arg conjugates  I 
Monitoring of in vivo activity 
of inducible nitric oxide 
synthase (iNOS) 
[111] 
 Lisinopril II 
Imaging of angiotensin-
convering enzyme (ACE) for 
hearth failure monitoring 
[112] 
 Insulin  II 
Tracing insulin biochemistry 
in vivo 
[113] 
 Aliphatic or aromatic ethers I, II Cardiac imaging [114] 
 Glu-urea-Lys, Glu-urea-Glu  I, II 
Imaging of prostate specific 
membrane antigen (PSMA) 
[115] 
 
DNA intercalator and bomesin 
analogue 
II 
Imaging gastrin releasing 
peptide receptor (GRPr) and 
Auger therapy 
[116] 
 
Duanidino, N-hydroxyguanidine, N-
methylguanidine, N-nitroguanidine or 
S-methylisothiurea moieties 
II iNOS visualization [117] 
 Ac-DEVD-R110-D-SAAC-Fmoc II Monitoring of apoptosis [118] 
 Pamidronate and alendronate I Bone imaging [119] 
 Bile acid I 
Radiopharmaceuticals for 
hepatobiliary diseases, liver 
tumor and intestinal cancer 
[120] 
N,N,O Pyridyl-tert-nitrogen-phenol ligand IV Radiolabeling agents [121] 
 Glucosamine IV 
Radiolabeling of glucose 
biochemistry 
[122,123] 
 4-Nitrobenzyl moiety IV 
Bioreductive diagnostic 
radiopharmaceutical 
[124] 
 
15-[N-(hydroxycarbonylmethyl)-2-
picolylamino)pentadecanoic acid 
V 
Radiotracer for evaluation of 
fatty acid metabolism in 
myocardium 
[125] 
 Estradiol VI 
Imaging agent for estrogen 
receptor in tumor cells 
[126] 
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Table 1. Cont. 
Denticity 
and Donor 
Atoms 
Conjugated Ligand  
Chelating 
Group 
Potential Medical Use Ref. 
 Triphenylphosphine VI 
Radioactive metalloprobes for 
in vivo monitoring of 
mitochondira 
[127] 
 Quinazoline derivatives IV 
Biomarker for EGFR-TK 
positive tumors 
[128] 
N,O,O 2- and 4-Nitroimidazole VII Imaging hypoxic cells [129–131] 
 
Glucosamino-Asp-cyclic(Arg-Gly-
Asp-D-Phe-Lys) 
VII Angiogenesis imaging agent [132] 
N,O,S Benzoyl thiourea VIII Radiopharmaceuticals [133] 
 Histidine derivatives IX Radiopharmaceuticals [134] 
 
3-(carboxymethylthio)-3-(1H-
imidazol-4-yl)propanoic acid 
X Radiopharmaceuticals [135] 
 Thymidine XI 
Monitoring activity human 
thymidine kinase type 1 
[136] 
Table 2. Synthesis of 99mTc complexes with chelating tetradentate N-containing ligands. 
Denticity 
and Donor 
Atoms 
Conjugated Ligand  
Chelating 
Group 
Potential Medical Use Ref. 
N,N,N,N 
2,2'-(1,4-diaminobutane)b8s(2-
methyl-3-butanone) dioxime 
i Hypoxia markers [137] 
 
1,4,8,11-tetra-azaundecane 
derivatives 
ii 
SPECT imaging probes for 
tumor imaging 
[138] 
N,N,N,S 2-nitroimidazole derivative iii Tumor hypoxia [139] 
 Probestin derivative iii 
Imaging aminipepetidase N 
(APN) expression in vivo 
[140] 
N,N,S,S 
Benzothiazole aniline, pyridyl 
benzofuran, phenylbenzoxazole, 
dibenzylideneacetone derivatives 
iv, v 
Beta-amyloid plaques imaging 
in brain 
[141–144] 
 2-quinolinecarboxamide iv 
Peripheral benzodiazepine 
receptor (PBR) imaging 
[145] 
N,S,S,S Fatty acid derivatives vi 
Myocardial metabolism 
imaging 
[146,147] 
 5-nitroimidazole derivatives vi Hypoxia tumor imaging [148] 
N,O,O,O Pteroyl-Lys derivative vii Tumor imaging [149] 
Tridentate complexes, with PNP chelating ligand as shown in Figure 35, have been reported. A 
couple of works reported the preparation of a lipophilic cationic 99mTc-DBODC complex  
(DBODC = dimethoxypropylphosphinoethyl)ethoxyethylamine) which was investigated as myocardial 
imaging agent [150–152]. The impact of bidentate chelators on lipophilicity, stability and 
biodistribution in Sprague-Dawley rats of a cationic 99mTc-nitrido complex with a similar PNP 
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tridentate ligand was studied; it was found that the metal complex was a very promising candidate for 
further preclinical studies in other animal models [153]. In a related work, a dithiocarbamate 
metronidazole derivative, potassium 2-(2-methyl-5-nitro-1H-imidazolyl)ethyldithiocarbamate, was 
synthesized and its complex with technetium was prepared in order to evaluate its potential as a tumor 
hypoxia marker [154]. The functionalization of the PNP tridentate ligand with fatty acid ligands was 
also explored, for being used as labelling agents to follow myocardial metabolism. The fatty acid 
derivatives were attached to one terminus of the carbon chain into a dithiocarbamate fragment [155]. 
Figure 35. Schematic representation of the chelating core of PNP tridentate ligands. 
 
Other metal complexes with different donor atoms were also reported. For example, carboxyl-rich 
thioether tridentate ligands were used to form technetium complexes and were used to measure 
effective renal plasma flow in rats. The complexes were formed from the reaction among 
[Tc(CO)3(H2O)3]+ at 70 °C and carboxymethylmercaptosuccinic acid or thiodisuccinic acid [156]. A 
bulky alkylphosphino-thiol bidentate ligand was used to form a complex with technetium; when 
reacted in the presence of a dithiocarbamate it was found that stable dissymmetrical mixed-substituted 
complexes were formed [157]. It was reported that these complexes may have potential applications as 
radiopharmaceuticals for imaging and therapy. Finally, a technetium-diethyl dithiocarbamate (DEDT) 
complex was prepared by a two-step procedure and studied as a potential brain radiopharmaceutical 
for brain imaging. Biodistribution in mice indicate that the complex is able to penetrate through the 
blood-brain-barrier (BBB), suggesting it may be potentially useful as a brain perfusion tracer [158]. 
From 2007 to the date, several research groups have explored the preparation of Tc(I) complexes 
based on ligands obtained by click chemistry. Click chemistry provides a useful synthetic tool for the 
preparation of multifunctional radiopharmaceuticals for several potential biomedical applications. 
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chelating systems for labeling 99mTc(CO)3 moieties, which presented good biodistribution and 
improved tumor detection [160,161]. A bidentate ligand containing a bioactive pharmacophore, (2-
methoxyphenyl)piperazine, has been prepared by this synthetic strategy, to further obtain a lipophilic 
technetium complex, potentially useful as a CNS imaging agent [162]. In other work, by the same 
group, the first example of a tridentate ligand obtained by click chemistry, was reported, and it was 
used to form a 99mTc(CO)3 complex for radioimaging [163]. Finally, a tetradentate ligand able to form 
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Tc(V) complexes was obtained by a “click-to-chelate” strategy, and its ability for being used as a  
in vivo radiotracer explored successfully [164]. 
B.4. Technetium Organometallic Complexes 
Technetium organometallic compounds were prepared as potential use for imaging and cancer 
therapy. A ferrocenyl triarylbutane derivative labeled with 99mTc by metal exchange reaction with 
[TcO4]− was synthesized and its in vivo biodistribution was determined in female Wistar rats, with 
promising results [165]. Causey and coworkers reported the synthesis and evaluation of mono- and  
di-aryl technetium metallocarborane derivatives [(RR'C2B9H9)Tc(CO)2(NO)] (R = p-PhOH, R' = H) as 
a new class of probes for estrogen receptors [166]. The technetium-carborane was generated using a 
cage isomerization process, in high yield (84%). In a closely related research, a functionalized 
carborane complex with 99mTc core, prepared by a microwave assisted approach, was studied for 
potential use as organometallic probes for in vitro and in vivo correlated imaging [167]. In a different 
work, long chain fatty acid analogs, labeled with 99mTc were prepared by linking at the omega-position 
of pentadecanoic acid acyclopentadienyltricarbonyltechnetium fragment [168]. The novel, lipophilic 
complex, was injected into rats and it was found to accumulate in myocardial tissue. It is a promising 
radiotracer for myocardial metabolism monitoring. In 2007, Miroslavov et al. developed a reasonable 
yield synthesis to prepare [Tc(CO)5X] (X = Cl−, Br−). From this compound, they were able to prepare 
the t-butyisocyanide and tripheynlphosphine derivatives, by halide substitution [169]. The preparation 
of a new cytectreene of general formula RCpTc(CO)3 (R = C6H5NHCO, Cp = cyclopentadyenyl) was 
prepared from N-phenylferrocenecarboxamide. The 99mTc complex was lipophilic enough to cross the 
BBB, making it an interesting base for the development of brain perfusion imaging agents [170]. 
Finally, in the quest for novel organometallic 99mTc imaging agents, water stable N-heterocyclic 
carbine complexes were prepared by the reaction of [TcO(glyc)2]− (glyc = ethyleneglycolato) with  
1,3-dimethylimidazoline-2-ylidene, 1,1'-methyelen-3,3'-dimethyl-4,40-dimidazoline-2,2'-diyldene and 
1,1'-methylene-3,3'-diethyl-4,4'-diimidazoline-2,20-diyldene in THF. Bidentate NHCs complexes were 
water-stable over a broad pH range, paves the way for the design of novel radiopharmaceuticals  
based on NHC complexes [171]. Figure 36 shows some selected examples of these technetium 
organometallic compounds. 
Figure 36. Selected technetium organometallic compounds. 
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B.5. Applications of Technetium Labeling to Nanomaterials 
In the dawn of nanoscience and nanotechnology, radiolabeled nanomaterials are becoming a 
common practice in the field. Multifunctional nanomaterials can simultaneously be used for diagnostic 
and therapy in a relatively young field called theranostics [172]. Then, radiotracers incorporated into 
nanomaterials make them useful as novel medical imaging agents, with the ability to penetrate through 
several biological barriers, fine tune their selectivity to specific targets and to modulate their 
biodistribution. This field is still young, but it can be prognosticated that in the future more advances 
and contributions will be available in the scientific literature. For example, PLA-PEG (polylactic acid-
polyethylene oxide) nanocapsules labeled with 99mTc-HMPAO (hexamethylpropylene-amine oxime) 
were prepared and their physical properties (size, size distribution, homogeneity) were determined by 
photon correlation spectroscopy and zeta potential by laser Doppler anemometry [173]. The results 
suggest that the radiolabeled nanocapsules were more stable against label leakage in the presence of 
proteins and could have better performances as radiotracers in vivo. In another work, polylactide-co-
glycolide (PLGA) nanoparticles containing chloramphenicol were obtained by emulsification solvent 
evaporation, using polyvinylalcohol (PVA) or polysorbate-80 (PS-80) as surfactants. The nanoparticles 
were radiolabeled with 99mTc by stannous reduction and their biodistribution after intravenous 
administration in mice was followed. Brain uptake was high, with low accumulation in bone marrow. 
The results are promising for the use of these systems for drug delivery and controlled release agents [174]. 
The use of technetium as radiolabeling agent to study the biodistribution of self-assembling protein 
nanoparticles allowed to determine their pharmacokinetic properties in vivo, in order to evaluate their 
usefulness as vaccine platforms [175]. In another work, pullulan acetate nanoparticles (PAN) were 
prepared by dialysis and radiolabeled with 99mTc with a 98% efficiency. The hydrophobic, spherical 
particles, with seizes in the range from 50 to 130 nm, were stable in aqueous suspensions and may be 
efficient for intratumoral administration [176]. Dendrimers belong to a special class of nanostructured 
materials with growing interest for pharmaceutical and biomedical use. Partially acetylated generation 
five polyamidoamine (PAMAM) dendrimer (G5-Ac) was reacted with biotin and 2-(p-
isothiocyanatobenzyl)-6-methyl-diethylenetriamine-pentaacetic acid and avidin to form a dendrimer-
avidin conjugate, which was radiolabeled with 99mTc. The nanostructured conjugate was evaluated for 
in vitro cellular uptake and biodistribution [177]. Finally, the preparation, characterization and 
biodistribution of letrozole loaded PLGA nanoparticles in tumor bearing mice was recently  
reported [178]. The PLGA nanoparticles were prepared by the solvent evaporation technique and 
characterized by TEM and DLS; radiolabeling with technetium was achieved with high efficiency and 
biodistribution indicate that the letrazole loaded nanoparticles present higher tumor uptake than usual 
drug delivery vehicles.  
Conclusions 
During the last 7–10 years (2007–2014), nearly 2,500 research papers have been published 
containing theoretical and experimental results on the chemistry of actinide and technetium metallic 
elements. They have revealed novel and interesting physical and chemical properties of their 
coordination and organometallic chemistry, in particular revealing fundamental information on their 
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unusual molecular and electronic structures and reactivity. For instance, the highest observed Werner 
coordination number (15) has been found in a Th complex with formula [Th(H3BNMe2BH3)4].Most of 
these complexes are formed by chelating, polydentate ligands containg O- and N-donor centers, but 
several heteroatom mixed ligands containing S-, P- ligands have been also explored. The solid state 
structures of these compounds has been extensively studied by single crystal X-ray crystallography in 
order to determine the variable and unique coordination modes of the several functional groups 
included into the ligands in order to coordinate toward the radioactive metal atoms. Talking about their 
usefulness, the design of complex, chelating, multidentate ligands can be applied in the processes of 
nuclear waste remediation (i.e., recycling of nuclear fuel and the selective separation of actinides and 
other fission products from waste solutions). Applications in analytical chemistry as specific ligands 
forrecongnition and determination of actinides in solutions has been also reported. Their rich and 
unique organometallic chemistry has also been heavily explored, and without any doubt still will keep 
showing in the future novel compounds with extraordinary properties and structures. Their bioactive 
properties, resulting from the radioactive and spontaneous emission of alpha or beta particles and/or 
gamma radiation, have been also explored for the design of novel antimicrobial and  
anti-fungalcompounds. In particular, the chemistry of technetium-99m (99mTc) short-lived metastable 
nuclide has been exploited for the preparation of metal complexeswith lipophilic ligands for brain and 
heart radioimaging, asa well as for radiolabeling antibiotics, steroids, peptides and other bioactive 
molecules, not only for tracking their fate into the organisms, which is of great help for  
pharmaco-kinetic studies or the understanding of metabolic pathways, but also for the preparation of 
novel in vivo imaging agents for diagnostics and therapy. A very promising field for the application of 
99mTc or Ac complexes or radiotracers is in the very explosive field of nanoscience and 
nanotechnology, in particular to the use of nanomaterials in health (nanomedicine). Their application 
for monitoring the biodistribution, accumulation and metabolism of radiolabeled nanomaterials 
designed for drug transport and controlled releasing, theranostic agents (simultaneous diagnostics and 
therapy agents in one material), medical imaging and other related biomedical applications, without 
any doubt will result in many interesting contributions in the near and far future, which will enrich the 
already extraordinary broad and productive field of research of radioactive metal complexes. 
Acknowledgments 
The authors are deeply thankful to the reviewers for the comments and suggestions made to 
improve this manuscript.  
Author Contributions 
All authors contribute equally to this work. Part A was done by BIK, OVK, UOM and PEM, while 
Part B was written by MAMR.  
Conflicts of Interest 
The authors declare no conflict of interest.  
  
Molecules 2014, 19 10790 
 
References 
1. Kirby, H.W.; Morss, L.R. Actinium. In The Chemistry of the Actinide and Transactinide 
Elements; Springer: Dordrecht, The Netherlands, 2006; Volume 1, pp. 18–51. 
2. Stavroula, S.; Kappel, B.J.; Jaggi, J.S.; McDevitt, M.R.; Scheinberg, D.A.; Sgouros, G. 
Enhanced retention of the α-particle emitting daughters of actinium-225 by liposome carriers. 
Bioconjugate Chem. 2007, 18, 2061–2067.  
3. Hudry, D.; Apostolidis, C.; Walter, O.; Griveau, J.-C.; Janssen, A.; Manara, D.; Colineau, E.; 
Vitova, T.; Wang, D.; Kübel, C.; et al. Ultra small plutonium oxide nanocrystals: Innovative 
building-blocks in plutonium. Science 2014, submitted. 
4. Hudry, D.; Griveau, J.-C.; Apostolidis, C.; Walter, O.; Colineau, E.; Rasmussen, G.; Wang, D.; 
Chakravadhaluna, V.S.K.; Courtois, E.; Kübel, C.; et al. Thorium/uranium mixed oxide 
nanocrystals: Synthesis, structural characterization and magnetic properties. Nano Res. 2014, 7, 
119–131. 
5. Hudry, D.; Apostolidis, C.; Walter, O.; Gouder, T.; Janssen, A.; Courtois, E.; Kübel, C.; Meyer, D. 
Synthesis of transuranium-based nanocrystals via the thermal decomposition of actinyl nitrates. 
RSC Adv. 2013, 3, 18271–18274. 
6. Hudry, D.; Apostolidis, C.; Walter, O.; Gouder, T.; Courtois, E.; Kübel, C.; Meyer, D. Controlled 
synthesis of thorium and uranium oxide nanocrystals. Chem. Eur. J. 2013, 19, 5297–5305.  
7. Morss, L.R. Synthetic milestones in f element inorganic chemistry. In Proceedings of the 7th 
International Conference on f Elements (ICfE-7), Cologne, Germany, 23–27 August 2009; 
Meyer, G., Ed.; NwT-Verlag: Bornheim, Germany, 2010; Volume 1, pp. 1–6.  
8. Fry, C.; Thoennessen, M. Discovery of the actinium, thorium, protactinium, and uranium 
isotopes. At. Data Nucl. Data Tables 2013, 99, 345–364. 
9. Cotton, S.C. Coordination chemistry of the actinides. In Lanthanide and Actinide Chemistry; 
John Wiley & Sons, Ltd.: Sussex, UK, 2006.  
10. Vlaisavljevich, B.; Mir, P.; Ma, D.; Sigmon, G.E.; Burns, P.C.; Cramer, C.J.; Gagliardi, L. 
Synthesis and characterization of the first 2d neptunyl structure stabilizedby side-on  
cation-cation interactions. Chem. Eur. J. 2013, 19, 2937–2941. 
11. Shiri, S.; Delpisheh, A.; Haeri, A.; Poornajaf, A.; Khezeli, T.; Badkiu, N. Floatation-
spectrophotometric determination of thorium, using complex formation with eriochrome 
cyaniner. Anal. Chem. Insights 2011, 6, 1–6.  
12. Uhrovcik, J.; Lesny, J. Contribution to validation of spectrophotometric determination  
ofthorium using Arsenazo III. HEJ: ENV-120131-A. Available online: 
http://heja.szif.hu/ENV/ENV-120131-A/env120131a.pdf (accessed on 16 July 2014). 
13. Jayarami, R.M.; Sudhavani, T.J.; Sivagangi, R. Synergistic extraction of uranium (VI) by 
complexation with CYANEX-272 and CYANEX-923, TPBD, TNBD, TOPO in presence of 
nitrate. Int. J. Res. Chem. Environ. 2012, 2, 158–163. 
14. Odoh, S.O.; Bylaska, E.J.; de Jong, W.A. Coordination and hydrolysis of plutonium ions in 
aqueous solution using car-parrinello molecular dynamics free energy simulations. J. Phys. 
Chem. A 2013, 117, 12256–12267. 
Molecules 2014, 19 10791 
 
15. Vercouter, T.; Vitorge, P.; Amekraz, B.; Giffaut, E.; Hubert, S.; Moulin, C. Stabilities  
of the Aqueous Complexes Cm(CO3)33− and Am(CO3)33− in the Temperature Range 10−70 °C. 
Inorg. Chem. 2005, 44, 5833–5843.  
16. Polinski, M.J.; Wang, S.; Alekseev, E.V.; Depmeier, W.; Liu, G.; Haire, R.G.; Albrecht-schmitt, T.E. 
Curium(III) borate shows coordination environments of both Plutonium(III) and Americium(III) 
borates. Angew. Chem. Int. Ed. 2012, 51, 1869–1872. 
17. Torapava, N.; Lundberg, D.; Persson, I. A coordination chemistry study of solvated Thorium(IV) 
ions in two oxygen-donor solvents. Eur. J. Inorg. Chem. 2011, 5273–5278.  
18. Rao, L.; Tian, G. Symmetry, optical properties and thermodynamicsof Neptunium(V) complexes. 
Symmetry 2010, 2, 1–14. 
19. Hennig, C.; Takao, S.; Takao, K.; Weiss, S.; Kraus, W.; Emmerling, F.; Meyer, M.; Scheinost, A.C. 
Identification of hexanuclear Actinide(IV) carboxylates withThorium, Uranium and Neptunium 
by EXAFS spectroscopy. J. Phys. Conf. Ser. 2013, 430, doi:10.1088/1742-6596/430/1/012116.  
20. Thakur, P.; Pathak, P.N.; Gedris, T.; Choppin, G.R. Complexation of Eu(III), Am(III) and 
Cm(III) with dicarboxylates: Thermodynamics and structuralaspects of the binary and ternary 
complexes. J. Solut. Chem. 2009, 38, 265–287. 
21. Barkleit, A.; Foerstendorf, H.; Heim, K.; Sachs, S.; Bernhard, G. Complex formation of 
uranium(vi) with l-phenylalanine and3-phenylpropionic acid studied by attenuated total 
reflection. Fourier transform infrared spectroscopy. Appl. Spectrosc. 2008, 62, 798–802. 
22. Mendes, M.; Hamadi, S.; le Naour, C.; Roques, J.; Jeanson, A.; Den Auwer, C.; Moisy, P.; 
Topin, S.; Aupiais, J.; Hennig, C.; et al. Thermodynamical and structural study of 
protactinium(v) oxalate complexes in solution. Inorg. Chem. 2010, 49, 9962–9971. 
23. Müller, M.; Acker, M.; Taut, S.; Bernhard, G. Complex formation of trivalent americium with 
salicylic acid at very low concentrations. J. Radioanal. Nucl. Chem. 2010, 286, 175–180.  
24. Mathur, J.N.; Cernochova, K.; Choppin, G.R. Thermodynamics and laser luminescence 
spectroscopy of binary and ternary complexation of Am3+, Cm3+ and Eu3+ with citric acid, and 
citric acid + EDTA at high ionic strength. Inorg. Chim. Acta 2007, 360, 1785–1791. 
25. Fedosseev, A.M.; Grigoriev, M.S.; Budantseva, N.A.; Guillaumont, D.; le Naour, C.;  
Simoni, E.; den Auwer, C.; Moisy, P. Americium(III) coordination chemistry: An unexplored 
diversity of structure and bonding. Comptes. Rendus. Chim. 2010, 13, 839–848.  
26. King, D.M.; Tuna, F.; McInnes, E.J.L.; McMaster, J.; Lewis, W.; Blake, A.J.; Liddle, S.T. 
Synthesis and structure of a terminal uranium nitride complex. Science 2012, 337, 717–720. 
27. Thomson, R.K.; Cantat, T.; Scott, B.L.; Morris, D.E.; Batista, E.R.; Kiplinger, J.L. Uranium 
azide photolysis results in C-H bondactivation and provides evidence for a terminaluranium 
nitride. Nat. Chem. 2010, 2, 723–729. 
28. Budantseva, N.A.; Grigoriev, M.S.; Fedoseev, A.M. Synthesis, structure, and absorption spectra 
of complex Neptunium(V) chromate with the guanidinium cation, [C(NH2)3]3[NpO2(CrO4)2] 
(H2O). Russ. J. Coord. Chem. 2013, 39, 360–365.  
29. Adam, C.; Kaden, P.; Beele, B.B.; Müllich, U.; Trumm, S.; Geist, A.; Panak, P.J.;  
Denecke, M.A. Evidence for covalence in a N-donor complex of Americium(III). Dalton Trans. 
2013, 42, 14068–14074.  
Molecules 2014, 19 10792 
 
30. Ölcer, A.; Amayri, S.; Reich, T. Neptunium coordination in room-temperature ionic liquids 
(BmimCl, BmimMsu and BmimSCN). Available online: http://www.kernchemie.uni-
mainz.de/downloads/JB2011/C07.pdf. (accessed on 16 July 2014). 
31. Kraft, S.J.; Fanwick, P.E.; Bart, S.C. Synthesis and characterization of a uranium(iii) complex 
containing a redox-active 2,2'-bipyridine ligand. Inorg. Chem. 2010, 49, 1103–1110. 
32. Takase, M.K.; Fang, M.; Ziller, J.W.; Furche, F.; Evans, W.J. Reduction chemistry of the mixed 
ligand metallocene [(C5Me5)(C8H8)U]2(η-C8H8) with bipyridines. Inorg. Chim. Acta 2010, 364, 
167–171. 
33. Zi, G.; Jia, L.; Werkema, E.L.; Walter, M.D.; Gottfriedsen, J.P.; Andersen, R.A. Preparation and 
Reactions of Base-Free Bis(1,2,4-tri-tert-butylcyclopentadienyl)uranium Oxide, Cp'2UO. 
Organometallics 2005, 24, 4251–4264. 
34. Mohammad, A.; Cladis, D.P.; Forrest, W.P.; Fanwick, P.E.; Bart, S.C. Reductive heterocoupling 
mediated by Cp*2U(2,2'-bpy). Chem. Commun. 2012, 48, 1671–1673. 
35. Ren, W.; Zi, G.; Walter, M.D. Synthesis, structure, and reactivity of a thorium metallocene 
containing a 2,2'-bipyridyl ligand. Organometallics 2012, 31, 672–679. 
36. Ren, W.; Song, H.; Zi, G.; Walter, M.D. A bipyridyl thorium metallocene: Synthesis, structure 
and reactivity. Dalton Trans. 2012, 41, 5965–5973. 
37. Antunes, M.A.; Pereira, L.C.J.; Santos, I.C.; Mazzanti, M.; Marçalo, J.; Almeida, M. 
[U(TpMe2)2(bipy)]+: A Cationic Uranium(III) complex withsingle-molecule-magnet behavior. 
Inorg. Chem. 2011, 50, 9915–9917. 
38. Hashem, E.; Lorusso, G.; Evangelisti, M.; McCabe, T.; Schulzke, C.; Platts, J.A.; Baker, R.J. 
Fingerprinting the oxidation state of U(IV) by emission spectroscopy. Dalton Trans. 2013, 42, 
14677–14680.  
39. Arnold, P.L.; Potter, N.A.; Magnani, N.; Apostolidis, C.; Griveau, J.-C.; Colineau, E.; 
Morgenstern, A.; Caciuffo, R.; Love, J.B. Synthesis of bimetallic uranium and neptunium 
complexes of a binucleating macrocycle and determination of the solid-state structure by 
magnetic analysis. Inorg. Chem. 2010, 49, 5341–5343. 
40. Ward, A.L.; Buckley, H.L.; Lukens, W.W.; Arnold, J. Synthesis and characterization of 
Thorium(IV) and Uranium(IV)corrole complexes. J. Am. Chem. Soc. 2013, 135, 13965–13971. 
41. Patkar, S.N.; Burungale, A.S.; Patil, R.J. Separation and liquid-liquid extraction of thorium(IV) 
as sulfate complex withsynergistic mixture of N-n-octylaniline and trioctylamine as an 
extractant. Rasayan. J. Chem. 2009, 2, 825–832.  
42. Manni, G.L.; Walensky, J.R.; Kraft, S.J.; Forrest, P.; Pérez, L.M.; Hall, M.B.; Gagliardi, L.;  
Bart, S.C. Computational insights into uranium complexes supported by redox-active α-diimine 
ligands. Inorg. Chem. 2012, 51, 2058–2064.  
43. Yin, H.; Lewis, A.J.; Williams, U.J.; Carroll, P.J.; Schelter, E.J. Fluorinated diarylamide 
complexes of Uranium(III, IV)incorporating ancillary fluorine-to-uranium dative interactions. 
Chem. Sci. 2013, 4, 798–805. 
44. Daly, S.R.; Piccoli, P.M.B.; Schultz, A.J.; Todorova, T.K.; Gagliardi, L.; Gilorami, G.S. 
Synthesis and properties of a fifteen-coordinate complex: The thorium aminodiboranate 
[Th(H3BNMe2BH3)4]. Angew. Chem. Int. Ed. 2010, 49, 3379–3381.  
Molecules 2014, 19 10793 
 
45. Choppin, G.R.; Thakur, P.; Mathur, J.N. Complexation thermodynamics and the structure  
of the binary and the ternary complexes of Am3+, Cm3+ and Eu3+ with IDAand EDTA + IDA. 
Inorg. Chim. Acta 2007, 360, 1859–1869. 
46. Marie, C.; Miguirditchian, M.; Guillaumont, D.; Tosseng, A.; Berthon, C.; Guilbaud, P.;  
Duvail, M.; Bisson, J.; Guillaneux, D.; Pipelier, M.; et al. Complexation of lanthanides(III), 
Americium(III), and Uranium(VI) with bitopic N,O ligands: An experimental and theoretical 
study. Inorg. Chem. 2011, 50, 6557–6566. 
47. Arnold, P.L.; Turner, Z.R.; Bellabarba, R.M.; Tooze, R.P. Carbon monoxide coupling and 
functionalisation at a simple uranium coordination complex. Chem. Sci. 2011, 2, 77–79. 
48. Gardner, B.M.; Stewart, J.C.; Davis, A.L.; McMaster, J.; Lewis, W.; Blake, A.J.; Liddle, S.T. 
Homologation and functionalization of carbonmonoxide by a recyclable uranium complex. Proc. 
Natl. Acad. Sci. USA 2012, 109, 9265–9270.  
49. Lapka, J.L.; Paulenova, A.; Zakharov, L.N.; Alyapyshev, M.Y.; Babain, V.A. Coordination of 
uranium(VI) with N,N'-diethyl-N,N'-ditolyldipicolinamide. IOP Conf. Ser.: Mater. Sci. Eng. 
2010, 9, doi:10.1088/1757-899X/9/1/012029. 
50. Carretta, S.; Amoretti, G.; Santini, P.; Mougel, V.; Mazzanti, M.; Gambarelli, S.; Colineau, E.; 
Caciuffo, R. Magnetic properties and chiral states of a trimetallic uranium complex. J. Phys. 
Condens. Matter 2013, doi:10.1088/0953-8984/25/48/486001. 
51. Alghool, S.; Abd El-Halim, H.F.; Abd El-sadek, M.S.; Yahia, I.S.; Wahab, L.A. Synthesis, 
thermal characterization, and antimicrobial activityof lanthanum, cerium, and thorium complexes 
of amino acidSchiff base ligand. J. Therm. Anal. Calorim. 2013, 112, 671–681. 
52. Agnihotri, S.; Arora, K. Physicochemical Investigations of Th(IV) and UO2(VI) complexes with 
new schiff basesalong with their toxic effects. Chem. Sci. Trans. 2010, 7, 1045–1054.  
53. Yadawe, M.S.; Patil, S.A. Synthesis and spectral characterization of Thorium(IV) complexes 
with 3-substituted-4-amino-5-mercapto-1,2,4-triazole schiff bases. Glob. J. Sci. Front. Res Chem. 
2012, 12, 41–44.  
54. Yaul, A.R.; Dhande, V.V.; Aswar, A. Synthesis, characterization, electrical and biological 
studies of VO(IV), MoO2(VI), WO2(VI), Th(IV) and UO2(VI) complexes with hydrazine ligand. 
Rev. Roum. Chim. 2010, 55, 537–542. 
55. ChandraSekhar Reddy, G.; Devanna, N.; Chandrasekhar, K.B. Sensitive spectrophotometric 
determination of Thorium(IV) using diacetyl monoxime isonicotinoyl hydrazine (DMIH). Int. J. 
Appl. Biol. Pharm. Technol. 2011, 2, 133–139. 
56. Patil, S.S.; Thakur, G.A.; Shaikh, M.M. Synthesis, characterization and antibacterial studies on 
some mixed ligand thorium complexes with N- and O-donor ligands. Acta Poloniae. Pharm. 
Drug Res. 2011, 68, 881–887. 
57. Kumar Verma, P. Synthesis, characterization and biocidal studies of rare earth metalcomplexes 
of diazepam. J. Appl. Chem. 2013, 2, 385–390.  
58. Law, G.L.; Andolina, C.M.; Xu, J.; Luu, V.; Rutkowski, P.J.; Muller, G.; Shuh, D.K.;  
Gibson, J.K.; Raymond, K.N. Circularly polarized luminescence of curium: A new 
characterization of the 5f actinide complexes. J. Am. Chem. Soc. 2012, 134, 15545–15549. 
Molecules 2014, 19 10794 
 
59. Andrea, T.; Barnea, E.; Botoshansky, M.; Kapon, M.; Genizi, E.; Goldschmidt, Z.; Eisen, M.S. 
Synthesis and characterization of new thorium and uraniumphenolate complexes. J. Organomet. 
Chem. 2007, 692, 1074–1080. 
60. Thuéry, P. Molecular and polymeric uranyl and thorium complexeswith sulfonate-containing 
ligands. Eur. J. Inorg. Chem. 2014, 2014, 58–68.  
61. Ramírez, F.M.; Varbanov, S.; Bünzli, J.-C.G.; Scopelliti, R. 5f-Element complexes with a p-tert-
butylcalix[4]arene bearing phosphinoyl pendant arms: Separation from rare earths and structural 
studies. Inorg. Chim. Acta 2011, 378, 163–168.  
62. Zhang, Y.; Bhadbhade, M.; Gao, J.; Karatchevtseva, I.; Price, J.R.; Lumpkin, G.R. Synthesis and 
crystal structures of uranium (VI) and thorium (IV)complexes with picolinamide and 
malonamide. Inorg. Chem. Commun. 2013, 37, 219–221.  
63. Kiegiel, K.; Steczek, L.; Zakrzewska-Trznadel, G. Application of calixarenes as macrocyclic 
ligands for Uranium(VI): A review. J. Chem. 2013, 2013, 762819. 
64. Wu, L.; Fang, Y.Y.; Jia, Y.M.; Yang, Y.Y.; Liao, J.L.; Liu, N.; Yang, X.S.; Feng, W.;  
Ming, J.L.; Yuan, L.H. Pillar[5]arene-based diglycolamides for highly efficient separation of 
americium(III) and europium(III). Dalton Trans. 2014, 43, 3835–3838. 
65. Tran, Q.H.; Le, V.T.; Nguyen, N.T. Spectroscopy method for determination of Thorium with 
Azocalix[4]arene. In Proceedings of the 2010 International Conference on Biology, Environment 
and Chemistry IPCBEE, Hong Kong, China, 28–30 December 2010; Yang Dan, Ed.; IACSIT 
Press: Singapore, 2011.  
66. Crawford, M.-J.; Mayer, P. Synthesis, structural and computational Investigations of UO2I42−:  
A Structurally characterized U(VI)-I anion. Inorg. Chem. 2005, 44, 5547–5549.  
67. Okude, G.; Fujii, T.; Uehara, A.; Sekimoto, S.; Minato, K.; Yamana, H. Unique extraction 
behavior of americium and curium in a system of TBP and calcium nitrate hydrate melt. IOP 
Conf. Ser. Mater. Sci. Eng. 2010, doi:10.1088/1757-899X/9/1/012067. 
68. Fujii, T.; Okude, G.; Uehara, A.; Yamana, H. Study on coordination characteristics of neptunium 
anduranium ions in calcium nitrate hydrate melt by Ramanspectrometry and UV/Vis/NIR 
spectrometry. IOP Conf. Ser. Mater. Sci. Eng. 2010, doi:10.1088/1757-899X/9/1/012061. 
69. Sarsfield, M.J.; Sims, J.E.; Taylor, R.J. Extraction of neptunium (IV) ions into 30% tri‐butyl 
phosphate from nitric acid. Solvent Extr. Ion. Exch. 2009, 27, 638–662. 
70. Borts, B.V.; Skoromnaya, S.F.; Tkachenko, V.I. Formation of associates from nanosized 
complexes of uranium in the water – supercritical carbon dioxide system. J. Kharkiv. Nat. Univ. 
2012, 355, 128–134. 
71. Vlaisavljevich, B.; Diaconescu, P.L.; Lukens, W.L., Jr.; Gagliardi, L.; Cummins, C.C. 
Investigations of the electronic structure of arene-bridgeddiuranium complexes. Organometallics 
2013, 32, 1341–1352. 
72. Webster, C.L.; Ziller, J.W.; Evans, W.J. Solvent-free organometallic reactivity: Synthesis of 
hydride and carboxylate complexes of uranium and yttrium from gas/solid reactions. 
Organometallics 2014, 33, 433–436. 
73. Ren, W.; Lukens, W.W.; Zi, G.; Maron, L.; Walter, M.D. Is the bipyridyl thorium metallocene a 
low-valentthorium complex? A combined experimental and computational study. Chem. Sci. 
2013, 4, 1168–1174.  
Molecules 2014, 19 10795 
 
74. Arnold, P.L.; Farnaby, J.H.; White, R.C.; Kaltsoyannis, N.; Gardiner, M.G.; Love, J.B. 
Switchable π-coordination and C–H metallation insmall-cavity macrocyclic uranium and thorium 
complexes. Chem. Sci. 2014, 5, 756–765. 
75. Thomson, R.K.; Graves, C.R.; Scott, B.L.; Kiplinger, J.L. Organometallic Uranium(IV) fluoride 
complexes: Preparation usingprotonolysis chemistry and reactivity with trimethylsilyl reagent. 
Dalton Trans. 2010, 39, 6826–6831.  
76. Bisson, J.; Dehaudt, J.; Charbonnel, M.-C.; Guillaneux, D.; Miguirditchian, M.; Marie, C.; 
Boubals, N.; Dutech, G.; Pipelier, M.; Blot, V.; et al. 1,10-Phenantroline and non-symmetrical 
1,3,5-triazine dipicolinamide-based ligands for group actinide extraction. Chem. Eur. J. 2014, 20, 
7819–7829. 
77. Benny, P.D.; Moore, A.L. Recent Advances in the Probe Development of Technetium-99m 
Molecular Imaging Agents. Curr. Org. Synth. 2011, 8, 566–583. 
78. Mei, L.; Chu, T. Technetium-99m Radiopharmaceutical Chemistry. Prog. Chem. 2011, 23, 
1493–1500. 
79. Liu, S.; Chakraborty, S. Tc-99m-centered one-pot synthesis for preparation of Tc-99m 
radiotracers. Dalton Trans. 2011, 40, 6077–6086. 
80. Jurgens, S.; Herrmann, W.A.; Künh, F.E. Rhenium and technetium based radiopharmaceuticals: 
Developments and recent advances. J. Organomet. Chem. 2014, 751, 83–89. 
81. Alberto, R. The particular role of radiopharmacy within bioorganometallic chemistry.  
J. Organomet. Chem. 2007, 692, 1179–1186. 
82. Bowen, M.L.; Orvig, C. 99m-Technetium carbohydrate conjugates as potential agents in 
molecular imaging. Chem. Commun. 2008, 41, 5077–5091. 
83. Mindt, T.; Struthers, H.; Garcia-Garoya, E.; Desbouis, D.; Schibli, R. Strategies for the 
development of novel tumor targeting technetium and rhenium radiopharmaceuticals. Chimia 
2007, 6, 725–731. 
84. Morais, M.; Paulo, A.; Gano, L.; Santos, I.; Correia, J.D.G. Target-specific Tc(CO)3− complexes 
for in vivo imaging. J. Organomet. Chem. 2013, 744, 125–139. 
85. Liu, S. Ether and crown ether-containing cationic Tc-99m complexes useful as radiopharmaceuticals 
for heart imaging. Dalton Trans. 2007, 12, 1183–1193. 
86. Sergienko, V.S.; Churakov, A.V. Specific features of technetium mononuclear octahedral oxo 
complexes: A review. Crystall. Rep. 2013, 58, 1–25. 
87. Triantis, C.; Tsotakos, T.; Tsoukalas, C.; Sagnou, M.; Raptopoulou, C.; Terzis, A.; Psycharis, V.; 
Pelecanou, M.; Pirmettis, I.; Papadopoulos, M. Synthesis and characterization of fac-
[M(CO)3(P)(OO)] and cis-trans-[M(CO)2(P)(2)(OO)] complexes (M=Re, Tc-99m) with 
acetylacetone and curcumin as OO donor bidentate ligands. Inorg. Chem. 2013, 52,  
12995–13003. 
88. Erfani, M.; Doroudi, A.; Hadisi, L.; Andishmand, A.; Mirshojaei, S.F.; Shafiei, M. Tc-99m-
tricarbonyl labeling of ofloxacin and its biological evaluation in Staphylococcus aureus as an 
infection imaging agent. J. Label. Compd. Rad. 2013, 56, 627–631. 
89. Qaiser, S.S.; Khan, A.U.; Khan, M.R. Synthesis, biodistribution and evaluation of Tc-99m-
sitafloxacin kit: A novel infection imaging agent. J. Radioanal. Nucl. Chem. 2010, 284, 189–193. 
Molecules 2014, 19 10796 
 
90. Motaleb, M.A. Preparation, quality control and stability of Tc-99m-sparafloxacin complex, a 
novel agent for detecting sites of infection. J. Label. Compd. Rad. 2009, 52, 415–418. 
91. Ibrahim, I.T.; Motaleb, M.A.; Attalah, K.M. Synthesis and biological distribution of Tc-99m-
norfloxacin complex, a novel agent for detecting sites of infection. J. Radioanal. Nucl. Chem. 
2010, 285, 431–436. 
92. Shah, S.Q.; Khan, A.U.; Khan, M.R. Radiosynthesis and biological evolution of Tc-99m(CO)(3)-
sitafloxacin dithiocarbamate complex: A promising Staphylococcus aureus infection radiotracer. 
J. Radioanal. Nucl. Chem. 2011, 288, 131–136. 
93. Shah, S.Q.; Khan, A.U.; Khan, M.R. Radiosynthesis and biodistribution of (TcN)-Tc-99m-
Garenoxacin dithiocarbamate complex a potential infection imaging agent. J. Radioanal. Nucl. 
Chem. 2011, 288, 56–94. 
94. Shah, S.Q.; Khan, M.R. Radiocomplexation and biological characterization of the (TcN)-Tc-
99m-trovafloxacin dithiocarbamate: A novel methicillin-resistant Staphylococcus aureus 
infection imaging agent. J. Radioanal. Nucl. Chem. 2011, 288, 215–220. 
95. Shah, S.Q.; Khan, A.U.; Khan, M.R. Radiosynthesis and biological evaluation of (TcN)-Tc-99m-
sitafloxacin dithiocarbamate as a potential radiotracer for Staphylococcus aureus infection.  
J. Radioanal. Nucl. Chem. 2011, 287, 827–832.  
96. Kyprianidou, P.; Tsoukalas, C.; Chiotellis, A.; Pagagiannopoulou, D.; Raptopoulou, C.P.;  
Terzis, A.; Pelecanou, M.; Papadopoulos, M.; Pirmettis, I. First example of well-characterized Re 
and Tc-99m tricarbonyl complexes of ciprofloxacin and norfloxacin in the development of 
infection-specific imaging agents. Inorg. Chim. Acta 2011, 370, 236–242. 
97. Ïlem-Özdemir, D.; Asikoglu, M.; Ozkilic, H.; Yilmaz, F.; Hosgor-Limoncu, M.; Ayhan, S.  
Tc-99m-doxycycline hyclate: A new radiolabeled antibiotic for bacterial infection imaging.  
J. Labelled. Compd. Rad. 2014, 57, 36–41. 
98. Tooyama, Y.; Braband, H.; Spingler, B.; Abram, U.; Alberto, R. High-valent technetium 
complexes with the [(TcO3)-Tc-99]+ core from in situ prepared mixed anhydrides of [(TcO4)-Tc-
99]− and their reactivities. Inorg. Chem. 2008, 47, 257–264. 
99. Gottschaldt, M.; Koth, D.; Müller, D.; Klette, I.; Rau, S.; Görfs, H.; Schäfer, B.; Baum, R.P.; 
Yano, S. Synthesis and structure of novel sugar-substituted bipyridine complexes of rhenium and 
99m-technetium. Chem. Eur. J. 2007, 13, 10273–10280. 
100. Bourkoula, A.; Paravatou-Petsotas, M.; Papadopoulos, A.; Santos, I.; Pietszch, H.J.;  
Livaniou, E.; Pelecanou, M.; Papadopoulos, M.; Pirmettis, I. Synthesis and characterization of 
rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline 
moiety as a biomarker for EGFR-TK imaging. Eur. J. Med. Chem. 2009, 44, 4021–4027. 
101. Ellis, B.L.; Gorshkov, N.I.; Lumpov, A.A.; Miroslavov, A.E.; Yalfimov, A.N.; Gurzhiy, V.V.; 
Suglobov, D.N.; Braddock, R.; Adams, J.C.; Smith, A.M.; et al. Synthesis, characterization and 
pre-clinical evaluation of Tc-99m-tricarbonyl complexes as potential myocardial perfusion 
imaging agents. J. Labelled. Compd. Rad. 2013, 56, 700–707. 
102. De, K.; Chandra, S.; Sarkar, B.; Ganguly, S.; Misra, M. Synthesis and biological evaluation of 
Tc-99m-DHPM complex: A potential new radiopharmaceutical for lung imaging studies.  
J. Radioanal. Nucl. Chem. 2010, 283, 621–628. 
Molecules 2014, 19 10797 
 
103. Thipyapong, K.; Uehara, T.; Tooyama, Y.; Braband, H.; Alberto, R.; Arano, Y. Insight into 
technetium amidoxime complex: Oxo technetium(v) complex of n-substituted benzamidoxime as 
new basic structure for molecular imaging. Inorg. Chem. 2011, 50, 992–998. 
104. Jia, J.H.; Cui, M.C.; Dai, J.; Wang, X.D.; Ding, Y.S.; Jia, H.; Liu, B. Tc-99m-labeled 
benzothiazole and stilbene derivatives as imaging agents for A beta plaques in cerebral amyloid 
angiopathy. MedChemComm 2014, 5, 153–158. 
105. Banerjee, S.R.; Foss, C.A.; Castanares, M.; Mease, R.C.; Byun, Y.; Fox, J.J.; Hilton, J.;  
Lupold, S.E.; Kozikowski, A.P.; Pomper, M.G. Synthesis and evaluation of technetium-99m-and 
rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA). J. Med. Chem. 
2008, 51, 4504–4517. 
106. Alves, S.; Correia, J.D.G.; Gano, L.; Rold, T.L.; Prasanphanich, A.; Haubner, R.; Rupprich, M.; 
Alberto, R.; Decristoforo, C.; Santos, I.; et al. In vitro and in vivo evaluation of a novel  
Tc-99m(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-D-Tyr-Lys). Bioconjugate Chem. 
2007, 18, 530–537. 
107. Raposinho, P.D.; Xavier, C.; Correia, J.D.G.; Falcao, S.; Gomes, P.; Santos, I. Melanoma 
targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[Tc-99m(CO)3]+: 
Effect of cyclization on tumor-seeking properties. J. Biol. Inorg. Chem. 2008, 13, 449–459. 
108. Maresca, K.P.; Marquis, J.C.; Hillier, S.M.; Lu, G.L.; Femia, F.J.; Zimmerman, C.N.;  
Eckelman, W.C.; Joyal, J.L.; Babich, J.W. Novel polar single amino acid chelates for 
technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: 
Application to octreotide. Bioconjugate Chem. 2010, 21, 1032–1042. 
109. Xavier, C.; Giannini, C.; Dall’Angelo, S.; Gano, L.; Maiorana, S.; Alberto, R.; Santos, I. 
Synthesis, characterization, and evaluation of a novel (99)mTc(CO)3 pyrazolyl conjugate of a 
peptide nucleic acid sequence. J. Biol. Inorg. Chem. 2008, 13, 1335–1344. 
110. Palma, E.; Oliveira, B.L.; Correia, J.D.G.; Gano, L.; Maria, L.; Santos, I.C.; Santos, I. A new 
bisphosphonate-containing Tc-99m(I) tricarbonyl complex potentially useful as bone-seeking 
agent: Synthesis and biological evaluation. J. Biol. Inorg. Chem. 2007, 12, 667–679. 
111. Oliveira, B.L.; Correia, J.D.G.; Raposinho, P.D.; Santos, I.; Ferreira, A.; Cordeiro, C.;  
Freire, A.P. Re and Tc-99m organometallic complexes containing pendant L-arginine derivatives 
as potential probes of inducible nitric oxide synthase. Dalton Trans. 2009, 1, 152–162. 
112. Femia, F.J.; Maresca, K.P.; Hillier, S.M.; Zimmerman, C.N.; Joyal, J.L.; Barret, J.A.; Aras, O.; 
Dilsizian, V.; Eckelman, W.C.; Babich, J.W. Synthesis and evaluation of a series of  
Tc-99m(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme 
expression. J. Nucl. Med. 2008, 49, 970–977. 
113. Sundararajan, C.; Besanger, T.R.; Labiris, R.; Guenther, K.J.; Stack, T.; Garafalo, R.;  
Kawabata, T.T.; Finco-Kent, D.; Zubieta, J.; Babich, J.W.; et al. Synthesis and characterization 
of rhenium and technetium-99m labeled insulin. J. Med. Chem. 2010, 53, 2612–2621. 
114. Maresca, K.P.; Kronauge, J.F.; Zubieta, J.; Babich, J.W. Novel ether-containing ligands as 
potential (99m)technetium(I) heart agents. Inorg. Chem. Commun. 2007, 10, 1409–1412. 
115. Lu, G.L.; Maresca, K.P.; Hillier, S.M.; Zimmerman, C.N.; Eckelman, W.C.; Joyal, J.L.;  
Babich, J.W. Synthesis and SAR of Tc-99m/Re-labeled small molecule prostate specific 
Molecules 2014, 19 10798 
 
membrane antigen inhibitors with novel polar chelates. Bioorg. Med. Chem. Lett. 2013, 23, 
1557–1563. 
116. Esteves, T.; Marques, F.; Paulo, A.; Rino, J.; Nanda, P.; Smith, C.J.; Santos, I. Nuclear targeting 
with cell-specific multifunctional tricarbonyl M(I) (M is Re, Tc-99m) complexes: Synthesis, 
characterization, and cell studies. J. Biol. Inorg. Chem. 2011, 16, 1141–1153. 
117. Oliveira, B.L.; Raposinho, P.D.; Mendes, F.; Santos, I.C.; Santos, I.; Ferreira, A.; Cordeiro, C.; 
Freire, A.P.; Correia, J.D.G. Targeting nitric oxide synthase with Tc-99m/Re-tricarbonyl 
complexes containing pendant guanidino or isothiourea moieties. J. Organomet. Chem. 2011, 
696, 1057–1065. 
118. Xiong, C.Y.; Lu, W.; Zhang, R.; Tian, M.; Tong, W.; Gelovani, J.; Li, C. Cell-permeable [Tc-
99m(CO)3]-labeled fluorogenic caspase 3 substrate for dual-modality detection of apoptosis. 
Chem. Eur. J. 2009, 15, 8979–8984. 
119. Palma, E.; Correia, J.D.G.; Oliveira, B.L.; Gano, L.; Santos, I.C.; Santos, I. Tc-99m(CO)3-
labeled pamidronate and alendronate for bone imaging. Dalton Trans. 2011, 40, 2787–2796. 
120. Huang, L.; Zhu, H.; Xu, X.; Zhang, C.; Shen, Y.-M. Synthesis and characterization of 
organometallic rhenium(I) and technetium(I) bile acid complexes. J. Organomet. Chem. 2009, 
694, 3247–3253. 
121. Lim, N.C.; Ewart, C.B.; Bowen, M.L.; Ferreira, C.L.; Barta, C.A.; Adam, M.J.; Orvig, C. 
Pyridine-tert-nitrogen-phenol ligands: N,N,O-type tripodal chelates for the [M(CO)3]+ core  
(M = Re, Tc). Inorg. Chem. 2008, 47, 1337–1345. 
122. Bowen, M.L.; Lim, N.C.; Ewart, C.B.; Misri, R.; Ferreira, C.L.; Hafeli, U.; Adam, M.J.;  
Orvig, C. Glucosamine conjugates bearing N,N,O-donors: Potential imaging agents utilizing the 
[M(CO)3]+ core (M = Re, Tc). Dalton Trans. 2009, 42, 9216–9227. 
123. Bowen, M.L.; Chen, Z.F.; Roos, A.M.; Misri, R.; Ferreira, C.L.; Häfeli, U.; Adam, M.J.;  
Orvig, C. Long-chain rhenium and technetium glucosamine conjugates. Dalton Trans. 2009, 42, 
9228–9236. 
124. Giglio, J.; Patsis, G.; Pirmettis, I.; Papadopoulos, M.; Raptopoulou, C.; Pelecanou, M.; Leon, E.; 
Gonzalez, M.; Cerecetto, H.; Rey, A. Preparation and characterization of technetium and 
rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive 
diagnostic radiopharmaceuticals. In vitro and in vivo studies. Eur. J. Med. Chem. 2008, 43,  
741–748. 
125. Lee, B.C.; Kim, D.H.; Lee, J.H.; Sung, H.J.; Choe, Y.S.; Chi, D.Y.; Lee, K.H.; Choi, Y.;  
Kim, B.-T. Tc-99m(CO)3–15-[N-(Acetyloxy)-2-picolylamino]pentadecanoic acid: A potential 
radiotracer for evaluation of fatty acid metabolism. Bioconjugate Chem. 2007, 18, 1332–1337. 
126. Neto, C.; Oliveira, M.C.; Gano, L.; Marques, F.; Thiemann, T.; Santos, I. Novel estradiol based 
metal complexes of Tc-99m. J. Inorg. Biochem. 2012, 111, 1–9. 
127. Moura, C.; Mendes, F.; Gano, L.; Santos, I.; Paulo, A. Mono- and dicationic Re(I)/Tc-99m(I) 
tricarbonyl complexes for the targeting of energized mitocondria. J. Inorg. Biochem. 2013, 123, 
34–45. 
128. Fernandes, C.; Santos, I.C.; Santos, I.; Pietzsch, H.J.; Kunstler, J.U.; Kraus, W.; Rey, A.; 
Margaritis, N.; Bourkoula, A.; Chiotellis, A.; et al. Rhenium and technetium complexes bearing 
Molecules 2014, 19 10799 
 
quinazoline derivatives: Progress towards a (99m)Tc biomarker for EGFR-TK imaging. Dalton 
Trans. 2008, 24, 3215–3225. 
129. Mallia, M.B.; Subramanian, S.; Mathur, A.; Sarma, H.D.; Venkatesh, M.; Banerjee, S. 
Comparing hypoxia-targeting of (99)mTc(CO)3-labeled 2-nitro 4-nitroimidazole. J. Label. 
Compd. Rad. 2008, 51, 308–313. 
130. Mallia, M.B.; Subramaniana, S.; Mathur, A.; Sarma, H.D.; Venkatesh, M.; Banerjee, S. 
Synthesis and evaluation of 2-, 4-, 5-substituted nitroimidazole-iminodiacetic acid-Tc-99m(CO)3 
complexes to target hypoxic tumors. J. Label. Compd. Rad. 2010, 53, 535–542. 
131. Mallia, M.B.; Subramanian, S.; Mathur, A.; Sarma, H.D.; Venkatesh, M.; Banerjee, S. On the 
isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target 
tumor hypoxia. Bioorg. Med. Chem. Lett. 2008, 18, 5233–5237. 
132. Lee, B.C.; Sung, H.J.; Kim, J.S.; Jung, K.H.; Choe, Y.S.; Lee, K.H.; Chi, D.Y. Synthesis of Tc-
99m labeled glucosamino-Asp-cyclic(Arg-Gly-Asp-D-Phe-Lys) as a potential angiogenesis 
imaging agent. Bioorg. Med. Chem. Lett. 2007, 15, 7755–7764. 
133. Nguyen, H.H.; Deflon, V.M.; Abram, U. Mixed-ligand complexes of technetium and rhenium 
with tridentate benzamidines and bidentate benzoylthioureas. Eur. J. Inorg. Chem. 2009, 21, 
3179–3187. 
134. Papagiannopoulou, D.; Tsoukalas, C.; Makris, G.; Raptopoulou, C.P.; Psycharis, V.;  
Leonidiadis, L.; Gdniazdowska, E.; Kozminski, P.; Fuks, L.; Pelecanou, M.; et al. Histidine 
derivatives as tridentate chelators for the fac-[M-I(CO)3] (Re, Tc-99m, Re-188) core: Synthesis, 
structural characterization, radiochemistry and stability. Inorg. Chim. Acta 2011, 378, 333–337. 
135. Papagiannopoulou, D.; Makris, G.; Tsoukalas, C.; Raptopoulou, C.P.; Terzis, A.; Pelecanou, M.; 
Pirmettis, I.; Papadopoulos, M.S. Rhenium(I) and technetium(I) fac-M(NSO)(CO)3 (M = Re,  
Tc-99m) tricarbonyl complexes, with a tridentate NSO bifunctional agent: Synthesis, structural 
characterization, and radiochemistry. Polyhedron 2010, 29, 876–880. 
136. Desbouis, D.; Struthers, H.; Spiwok, V.; Küster, T.; Schibli, R. Synthesis, in vitro, and in silico 
evaluation of organometallic technetium and rhenium thymidine complexes with retained 
substrate activity toward human thymidine kinase type 1. J. Med. Chem. 2008, 51, 6689–6698. 
137. Sun, X.; Chu, T.W.; Wang, X.Y. Preliminary studies of Tc-99m-BnAO and its analogues: 
Synthesis, radiolabeling and in vitro cell uptake. Nucl. Med. Biol. 2010, 37, 117–123. 
138. Abiraj, K.; Mansi, R.; Tamma, M.L.; Forrer, F.; Cescato, R.; Reubi, J.C.; Akyel, K.G.; 
Maecke, H.R. Tetraamine-derived bifunctional chelators for technetium-99m labelling: 
Synthesis, Bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-
positive tumours. Chem. Eur. J. 2010, 16, 2115–2124. 
139. Joyard, Y.; Le Joncur, V.; Castel, H.; Diouf, C.B.; Bischoff, L.; Papamicaël, C.; Levacher, V.; 
Vera, P.; Bohn, P. Synthesis and biological evaluation of a novel Tc-99m labeled 2-nitroimidazole 
derivative as a potential agent for imaging tumor hipoxia. Bioorg. Med. Chem. Lett. 2013, 23, 
3074–3078. 
140. Pathuri, G.; Hedrick, A.F.; Disch, B.C.; Doan, J.T.; Ihnat, M.A.; Awasthi, V.; Gali, H. Synthesis 
and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression 
in vivo. Bioconjugate Chem. 2012, 23, 115–124. 
Molecules 2014, 19 10800 
 
141. Chen, X.J.; Yu, P.R.; Zhang, L.F.; Liu, B. Synthesis and biological evaluation of Tc-99m, Re-
monoamine-monoamide conjugated to 2-(4-aminophenyl) benzothiazole as potential probes for 
beta-amyloid plaques in the brain. Bioorg. Med. Chem. Lett. 2008, 18, 1442–1445. 
142. Cheng, Y.; Ono, M.; Kimura, H.; Ueda, M.; Saji, H. Technetium-99m Labeled Pyridyl 
Benzofuran Derivatives as Single Photon Emission Computed Tomography Imaging Probes for 
beta-Amyloid Plaques in Alzheimer's Brains. J. Med. Chem. 2012, 55, 2279–2286. 
143. Wang, X.; Cui, M.; Yu, P.; Li, Z.; Yang, Y.; Jia, H.; Liu, B. Synthesis and biological evaluation 
of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for 
beta-amyloid plaques in brain. Bioorg. Med. Chem. Lett. 2012, 22, 4327–4331. 
144. Yang, Y.; Cui, M.; Jin, B.; Wang, X.; Li, Z.; Yu, P.; Jia, J.; Fu, H.; Jia, H.; Liu, B.  
Tc-99m-labeled dibenzylideneacetone derivatives as potential SPECT probes for in vivo imaging 
of beta-amyloid plaque. Eur. J. Med. Chem. 2013, 64, 90–98. 
145. Cappelli, A.; Mancini, A.; Sudati, F.; Valenti, S.; Anzini, M.; Belloi, S.; Moresco, R.M.; 
Matarrese, M.; Vaghi, M.; Fabro, A.; et al. Synthesis and biological characterization of novel 2-
quinolinecarboxamide ligands of the peripheral benzodiazepine receptors bearing technetium-
99m or rhenium. Bioconjugate Chem. 2008, 19, 1143–1153. 
146. Walther, M.; Jung, C.M.; Bergmann, R.; Pietzsch, J.; Rode, K.; Fahmy, K.; Mirtschink, P.;  
Stehr, S.; Heintz, A.; Wunderlich, G.; et al. Synthesis and biological evaluation of a new type of 
(99m)Technetium-labeled fatty acid for myocardial metabolism imaging. Bioconjugate Chem. 
2007, 18, 216–230. 
147. Mirschink, P.; Stehr, S.N.; Pietzsch, H.J.; Bergmann, R.; Pietzsch, J.; Wunderlich, G.;  
Heintz, A.C.; Kropp, J.; Spies, H.; Kraus, W.; Deussen, A.; et al. Modified "4+1" mixed ligand 
technetium-labeled fatty acids for myocardial imaging: Evaluation of myocardial uptake and 
biodistribution. Bioconjugate Chem. 2008, 19, 97–108. 
148. Giglio, J.; Fernandez, S.; Pietzsch, H.J.; Dematteis, S.; Moreno, M.; Pacheco, J.P.; Cerecetto, H.; 
Rey, A. Synthesis, in vitro and in vivo characterization of novel Tc-99m-'4+1'-labeled 5-nitroimidazole 
derivatives as potential agents for imaging hypoxia. Nucl. Med. Biol. 2012, 39, 679–686. 
149. Guo, H.; Xie, F.; Zhu, M.; Li, Y.; Yang, Z.; Wang, X.; Lu, J. The synthesis of pteroyl-lys 
conjugates and its application as Technetium-99m labeled radiotracer for folate receptor-positive 
tumor targeting. Bioorg. Med. Chem. Lett. 2011, 21, 2025–2029. 
150. Bolzati, C.; Carta, D.; Gandin, V.; Marzano, C.; Morellato, N.; Salvarese, N.; Cantore, M.; 
Colabufo, N.A. Tc-99m(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug 
resistance: In vitro study. J. Biol. Inorg. Chem. 2013, 18, 523–538. 
151. Bolzati, C.; Cavazza-Ceccato, M.; Agostini, S.; Tokunaga, S.; Casara, D.; Bandoli, G. 
Subcellular distribution and metabolism studies of the potential myocardial imaging agent 
[99mTc(N)(DBODC)(PNP5)]+. J. Nucl. Med. 2008, 49, 1336–1344. 
152. Cittanti, C.; Uccelli, L.; Pasquali, M.; Boschi, A.; Flammia, C.; Bagatin, E.; Casali, M.;  
Stabin, M.G.; Feggi, L.; Giganti, M.; et al. Whole-body biodistribution and radiation dosimetry 
of the new cardiac tracer Tc-99m-N-DBODC. J. Nucl. Med. 2008, 49, 1299–1304. 
153. Liu, S.; He, Z.J.; Hsieh, W.-Y.; Kim, Y.-S. Impact of bidentate chelators on lipophilicity, 
stability, and biodistribution characteristics of cationic Tc-99m-nitrido complexes. Bioconjugate 
Chem. 2007, 18, 929–936. 
Molecules 2014, 19 10801 
 
154. Kong, D.J.; Lu, J.; Ye, S.Z.; Wang, X.B. Synthesis and biological evaluation of a novel 
asymmetrical Tc-99m-nitrido complex of metronidazole derivative. J. Label. Compd. Rad. 2007, 
50, 1137–1142. 
155. Cazzola, E.; Benini, E.; Pasquali, M.; Mirtschink, P.; Walther, M.; Pietzsch, H.J.; Uccelli, L.; 
Boschi, A.; Bolzati, C.; Duatti, A. Labeling of fatty acid ligands with the strong electrophilic 
metal fragment [Tc-99m(N)(PNP)]2+ (PNP = diphosphane ligand). Bioconjugate Chem. 2008, 19, 
450–460. 
156. He, H.; Lipowska, M.; Christoforou, A.M.; Marzilli, L.G.; Taylor, A.T. Initial evaluation of new 
(TC)-T-99m(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical 
characterization of Re(CO)3 analogues. Nucl. Med. Biol. 2007, 34, 709–716. 
157. Bolzati, C.; Cavazza-Ceccato, M.; Agostini, S.; Tisato, F.; Bandoli, G. Technetium and rhenium 
in five-coordinate symmetrical and dissymmetrical nitrido complexes with alkyl phosphino-thiol 
ligands. Synthesis and structural characterization. Inorg. Chem. 2008, 47, 11972–11983. 
158. Zhang, J.; Wang, X.; Jin, C. Synthesis and biodistribution of the 99mTc(CO)3-DEDT complex as a 
potential new radiopharmaceutical for brain imaging. J. Radioanal. Nucl. Chem. 2007, 272,  
91–94.  
159. Hayes, T.R.; Kasten, B.B.; Barnes, C.L.; Benny, P.D. Rhenium and technetium bi- and 
tricarbonyl complexes in a new strategy for biomolecule incorporation using click chemistry. 
Dalton Trans. 2014, 43, 6998–7001. 
160. Brans, L.; García-Garayoa, E.; Schweinsberg, C.; Maes, V.; Struthers, H.; Schibli, R.; Tourwé, D. 
Synthesis and evaluation of bombesin analogues conjugataed to two different triazolyl-derived 
chelators for 99mTc labeling. Chem. Med. Chem. 2010, 5, 1717–1725. 
161. Mindt, T.L.; Struthers, H.; Spingler, B.; Brans, L.; Tourwé, D.; García-Garayoa, E.; Schibli, R. 
Molecular assembly of multifunctional 99mTc radiopharmaceuticals using “clickable” amino acid 
derivatives. Chem. Med. Chem. 2010, 5, 2026–2038. 
162. Seridi, A.; Wolff, M.; Boulay, A.; Saffon, N.; Coulais, Y.; Picard, C.; Machura, B.; Benoist, E. 
Rhenium(I) and technetium(I) complexes of a novel pyridyltriazole-based ligand containing an 
arylpiperazine pharmacophore: Synthesis, crystal structures, computational studies and 
radiochemistry. Inorg. Chem. Commun. 2011, 14, 238–242. 
163. Guizani, S.; Saied, N.M.; Picard, C.; Benoist, E.; Saidi, M. Synthesis and preliminary biological 
evaluation of the first 99mTc(I)-specific semi-rigid tridentate ligand based on a click chemistry 
strategy. J. Label. Compd. Radiopharm. 2014, 57, 158–163. 
164. Martinage, O.; le Clainche, L.; Czarny, B.; Dugave, C. Synthesis and biological evaluation of a 
new triazole-oxotechnetium complex. Org. Biomol. Chem. 2012, 10, 6484–6490. 
165. Dallagi, T.; Saidi, M.; Vessieres, A.; Huché, M.; Jaouen, G.; Top, S. Synthesis and 
antiproliferative evaluation of ferrocenyl and cymantrenyl triaryl butene on breast cancer cells. 
Biodistribution study of the corresponding technetium-99m tamoxifen conjugate. J. Organomet. 
Chem. 2013, 734, 69–77. 
166. Causey, P.W.; Besanger, T.R.; Valliant, J.F. Synthesis and screening of mono- and di-aryl 
technetium and rhenium metallocarboranes. A new class of probes for the estrogen receptor.  
J. Med. Chem. 2008, 51, 2833–2844. 
Molecules 2014, 19 10802 
 
167. Armstrong, A.F.; Lebert, J.M.; Brennan, J.D.; Valliant, J.F. Functionalized carborane complexes 
of the [M(CO)2(NO)]2+ core (M=Tc-99m, Re): A new class of Organometallic probes for 
correlated in vitro and in vivo imaging. Organometallics 2009, 28, 2986–2992. 
168. Uehara, T.; Uemura, T.; Hirabayashi, S.; Adachi, S.; Odaka, K.; Akizawa, H.; Magata, Y.;  
Irie, T.; Arano, Y. Technetium-99m-labeled long chain fatty acid analogues metabolized by  
beta-oxidation in the heart. J. Med. Chem. 2007, 50, 543–549. 
169. Miroslavov, A.E.; Lumpov, A.A.; Sidorenko, G.V.; Levitskaya, E.M.; Gorshkov, N.I.;  
Suglobov, D.N.; Alberto, R.; Braband, H.; Gurzhiy, V.V.; Krivovichev, S.V.; et al. Complexes 
of technetium(I) (Tc-99, Tc-99m) pentacarbonyl core with pi-acceptor ligands (tert-butyl 
isocyanide and triphenylphosphine): Crystal structures of [Tc(CO)5(PPh3)]OTf and 
[Tc(CO)5(CNC(CH3)3)]ClO4. J. Organomet. Chem. 2008, 693, 4–10. 
170. Malek-Saied, N.; El Aissi, R.; Ladeira, S.; Benoist, E. Synthesis and biological evaluation of a 
novel Tc-99m-cyclopentadienyltricarbonyl technetiumcomplex as a new potential brain 
perfusion imaging agent. Appl. Organomet. Chem. 2011, 25, 680–686. 
171. Benz, M.; Spingler, B.; Alberto, R.; Braband, H. Toward organometallic tc-99m imaging Agents: 
Synthesis of water-stable Tc-99-Nhc complexes. J. Am. Chem. Soc. 2013, 135, 17566–17572. 
172. Morales-Avila, E.; Ferro-Flores, G.; Ocampo-García, B.E.; Ramírez, F.M. Radiolabeled 
nanoparticles for molecular imaging. Mol. Imaging 2012, doi:10.5772/31109. 
173. Pereira, M.A.; Mosqueira, V.C.; Vilela, J.M.C.; Andrade, M.S.; Ramaldes, G.A.; Cardoso, V.N. 
PLA-PEG nanocapsules radiolabeled with (99m)Technetium-HMPAO: Release properties and 
physicochemical characterization by atomic force microscopy and photon correlation 
spectroscopy. Eur. J. Pharm. Sci. 2008, 33, 42–51. 
174. Halder, K.K.; Mandal, B.; Debnath, M.C.; Bera, H.; Ghosh, L.K.; Gupta, B.K. Chloramphenicol-
incorporated poly lactide-co-glycolide (PLGA) nanoparticles: Formulation, characterization, 
technetium-99m labeling and biodistribution studies. J. Drug Targ. 2008, 16, 311–320. 
175. Yang, Y.; Neef, T.; Mittelholzer, C.; Garayoa, E.G.; Blaunstein, P.; Schibli, R.; Aebi, U.; 
Burkhard, P. The biodistribution of self-assembling protein nanoparticles shows they are 
promising vaccine platforms. J. Nanobiotech. 2013, doi:10.1186/1477-3155-11-36.  
176. Park, K.H.; Song, H.C.; Na, K.; Born, H.S.; Lee, K.H.; Kim, S.; Kang, D.; Lee, D.H. Ionic 
strength-sensitive pullulan acetate nanoparticles (PAN) for intratumoral administration of 
radioisotope: Ionic strength-dependent aggregation behavior and (99m)Technetium retention 
property. Colloids Surf. B 2007, 59, 16–23. 
177. Xu, X.P.; Zhang, Y.Q.; Wang, X.D.; Guo, X.X.; Zhang, X.Z.; Qi, Y.J.; Shen, Y.M. 
Radiosynthesis, biodistribution and micro-SPECT imaging study of dendrimer-avidin conjugate. 
Bioorg. Med. Chem. 2011, 19, 1643–1648. 
178. Mondal, N.; Halder, K.K.; Kamila, M.M.; Debnath, M.C.; Pal, T.K.; Ghosal, S.K.; Sarkar, B.R.; 
Ganguly, S. Preparation, characterization, and biodistribution of letrozole loaded PLGA 
nanoparticles in Ehrlich Ascites tumor bearing mice. Int. J. Pharm. 2010, 397, 194–200. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
